Επιστημονικές Δημοσιεύσεις

Publications
  • Stathopoulos P, Kalogerakos G, Kakoullis SA, Michaeloudes C, Falagas ME; Pharmacological thromboprophylaxis in hospitalized patients with acute infectious diseases: a meta-analysis. Eur J Clin Pharmacol. 2026 Jul 21;82(8):213. doi: 10.1007/s00228-026-04140-5.
  • Falagas ME, Kontogiannis DS, Chatzimichalis M, Raffay V; An evaluation of PubMed Central as a resource of free full-text articles for systematic reviews in biomedical research and education. Postgrad Med J. 2026 Jul 21;102(1210):734-739. doi: 10.1093/postmj/qgag015.
  • Fanariotis G, Poziou P, Romanos LT, Tzvetanova ID, Falagas ME; Resistance to Plazomicin: An Analysis of the Evidence from In Vitro Antimicrobial Susceptibility Studies. Antibiotics. 2026 May 30;15(6):559. doi: 10.3390/antibiotics15060559.
  • Falagas ME, Katritsi ED, Kontogiannis DS, Katsikas KM, Tzvetanova ID; Resistance of gram-negative and gram-positive pathogens to omadacycline: a systematic review. Eur J Clin Microbiol Infect Dis. 2026 May 26. doi: 10.1007/s10096-026-05553-x.
  • Falagas ME, Kontogiannis DS, Ragias D, Filippou C; A systematic review of data on the resistance of uropathogens to sulopenem. Eur J Clin Microbiol Infect Dis. 2026 May;45(5):1225-1236. doi: 10.1007/s10096-026-05420-9.
  • Falagas ME, Ragias D, Kontogiannis DS, Romanos LT, Farazi PA; Proposed Risk of Bias Assessment Tool for In Vitro Antimicrobial Susceptibility Studies. Pathogens. 2026 Apr 7;15(4):396. doi: 10.3390/pathogens15040396.
  • Stathopoulos P, Bousi SE, Kakoullis SA, Michaeloudes C, Falagas ME; Infections as a dynamic trigger for venous thromboembolism: toward clinically actionable risk stratification. Eur J Intern Med.2026 Apr:146:106797. doi: 10.1016/j.ejim.2026.106797. Epub 2026 Feb 26.
  • Falagas ME, Romanos LT, Katritsi ED, Tzvetanova ID; Resistance of uropathogens to gepotidacin: A systematic review of in vitro antimicrobial susceptibility studies. Int J Antimicrob Agents. 2026 Apr;67(4):107723. doi: 10.1016/j.ijantimicag.2026.107723.
  • Falagas ME, Asimotou CM, Kontogiannis DS, Romanos LT, Poziou P, Tzvetanova ID; Resistance of Uropathogens to Tebipenem: An Analysis of the Evidence from In Vitro Antimicrobial Susceptibility Studies. Microorganisms. 2026 Mar 23;14(3):726. doi: 10.3390/microorganisms14030726.
  • Ragias D, Tzikopoulou M, Falagas ME; Venous thromboembolism in professional drivers of automatic transmission vehicles: an underestimated occupational risk?. Postgrad Med J. 2026 Mar 17;102(1206):365-366. doi: 10.1093/postmj/qgaf074.
  • Falagas ME, Fanariotis G, Romanos LT, Katsikas KM, Kakoullis SA; Resistance to Lefamulin: An Evaluation of Data from In Vitro Antimicrobial Susceptibility Studies. Antibiotics (Basel). 2026 Jan 5;15(1):58. doi: 10.3390/antibiotics15010058.
  • Falagas ME, Kontogiannis DS, Sargianou M, Bousi SE, Ntourakis D; Colistin monotherapy versus colistin combination therapy in the treatment of patients with multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a meta-analysis. J Hosp Infect. 2026 Jan:167:211-231. doi: 10.1016/j.jhin.2025.10.019.
  • Falagas ME, Romanos LT, Kontogiannis DS, Filippou C; Resistance of Gram-negative bacteria to aztreonam-avibactam: An evaluation of data from in vitro studies. Int J Antimicrob Agents. 2025 Dec;66(6):107624. doi: 10.1016/j.ijantimicag.2025.107624.
  • Stathopoulos P, Bousi SE, Zachiotis M, Lampropoulos A, Kakoullis SA, Michaeloudes C, Falagas ME; Venous thromboembolism associated with infections: a systematic review and meta-analysis. Eur J Intern Med. 2025 Dec:142:106448. doi: 10.1016/j.ejim.2025.106448.
  • Falagas ME, Romanos LT, Kontogiannis DS, Filippou C, Karageorgopoulos DE; Resistance of Gram-Negative Bacteria to Eravacycline: A Systematic Review of Data from In Vitro Studies. Pathogens. 2025 Nov 28;14(12):1214. doi: 10.3390/pathogens14121214.
  • Falagas ME, Romanos LT, Hopkins A, Sioulas A, Tsitskari M; Concealed Peritonitis Due to Stomach Perforation from a Fish Otolith: A Case Report. Reports (MDPI). 2025 Nov 28;8(4):252. doi: 10.3390/reports8040252.
  • Falagas ME, Kontogiannis DS, Romanos LT, Ragias D, Agoranou ME, Kakoullis SA; Intravenous Fosfomycin for Gram-Negative and Gram-Positive Bacterial Infections: A Systematic Review of the Clinical Evidence. Antibiotics (Basel). 2025 Nov 23;14(12):1193. doi: 10.3390/antibiotics14121193.
  • Falagas ME, Kontogiannis DS, Sargianou M, Kakoullis SA; In vitro antimicrobial activity and clinical use of trimethoprim-sulfamethoxazole for infections due to KPC-producing Gram-negative pathogens: a review. Eur J Clin Microbiol Infect Dis. 2025 Nov;44(11):2559-2568. doi: 10.1007/s10096-025-05236-z. 
  • Falagas ME, Stathopoulos P, Kontogiannis DS, Tzvetanova ID; Antibiotics for Rheumatologic Diseases: A Critical Review. Int J Mol Sci. 2025 Oct 29;26(21):10527. doi: 10.3390/ijms262110527.
  • Falagas ME, Romanos LT, Ragias D, Filippou C; Resistance of Acinetobacter baumannii Complex Clinical Isolates to Sulbactam-Durlobactam: A Systematic Review of Data from In Vitro Studies. Pathogens. 2025 Oct 20;14(10):1062. doi: 10.3390/pathogens14101062.
  • Falagas ME, Kontogiannis DS, Ragias D, Kakoullis SA; Antibiotics for the Treatment of Patients with Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacterial Infections. Antibiotics (Basel). 2025 Sep 4;14(9):894. doi: 10.3390/antibiotics14090894.
  • Kontogiannis DS, Romanos LT, Tzvetanova ID, Voulgaris GL, Falagas ME; Antibiotics and non-traditional antimicrobial agents for carbapenem-resistant Acinetobacter baumannii in Phase 1, 2, and 3 clinical trials. Expert Opin Investig Drugs. 2025 Sep;34(9):705-716. doi: 10.1080/13543784.2025.2552846.
  • Vrysis C, Kontogiannis DS, Ntourakis D, Kakoullis SA, Falagas ME; Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review. Expert Rev Anti Infect Ther. 2025 Sep;23(9):691-703. doi: 10.1080/14787210.2025.2532024. 
  • Vrysis C, Katsarou A, Lytras T, Katsikas K, Falagas ME; Rash associated with antibiotic administration in patients with infectious mononucleosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2025 Sep;44(9):2183-2196. doi: 10.1007/s10096-025-05189-3. 
  • Falagas ME, Kontogiannis DS, Sargianou M, Falaga EM, Chatzimichali M, Michaeloudes C; Probiotic-Based Cleaning Solutions: From Research Hypothesis to Infection Control Applications. Biology (Basel). 2025 Aug 13;14(8):1043. doi: 10.3390/biology14081043.
  • Falagas ME, Romanos LT, Kontogiannis DS, Tsiara K, Kakoullis SA; Resistance of Gram-Negative Bacteria to Cefepime-Enmetazobactam: A Systematic Review. Pathogens. 2025 Aug 6;14(8):777. doi: 10.3390/pathogens14080777.
  • Falagas ME, Paliogianni PM, Kontogiannis DS, Ragias D, Johnson E; Google Scholar as a Resource for Systematic Reviews in Clinical Medicine. J Eval Clin Pract. 2025 Aug;31(5):e70206. doi: 10.1111/jep.70206.
  • Kontogiannis DS, Agoranou ME, Dimitriadis F, Skouteris VM, Falagas ME; Fosfomycin for the treatment of patients with bacterial prostatitis: a systematic review. Eur J Clin Microbiol Infect Dis. 2025 Aug;44(8):1835-1848. doi: 10.1007/s10096-025-05173-x.
  • Falagas ME, Asimotou C-M, Zidrou M, Kontogiannis DS, Filippou C; Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review. Microorganisms. 2025 Jul 19;13(7):1697. doi: 10.3390/microorganisms13071697.
  • Stathopoulos P, Romanos LT, Loutradis C, Falagas ME; Nephrotoxicity of New Antibiotics: A Systematic Review. Toxics. 2025 Jul 19;13(7):606. doi: 10.3390/toxics13070606.
  • Athanasiou V, Ragias D, Tzikopoulou M, Zenios M, Falagas ME; Tedizolid for osteoarticular infections: Evaluation of the published evidence. Eur J Pharmacol. 2025 Jul 5:998:177458. doi: 10.1016/j.ejphar.2025.177458. Epub 2025 Mar 14.
  • Romanos LT, Kontogiannis DS, Tsiampali C, Tzvetanova ID, Falagas ME; Antibiotics and non-traditional antimicrobial agents for Pseudomonas aeruginosa in clinical phases 1, 2, and 3 trials. Expert Opin Investig Drugs. 2025 Jul-Aug;34(7-8):639-653. doi: 10.1080/13543784.2025.2532443. 
  • Falagas ME, Kontogiannis DS, Zidrou M, Filippou C, Tansarli GS; Global Epidemiology and Antimicrobial Resistance of Metallo-β-Lactamase (MBL)-Producing Acinetobacter Clinical Isolates: A Systematic Review. Pathogens. 2025 Jun 3;14(6):557. doi: 10.3390/pathogens14060557.
  • Sargianou M, Stathopoulos P, Vrysis C, Tzvetanova ID, Falagas ME;  New β-Lactam/β-Lactamase Inhibitor Combination Antibiotics. Pathogens. 2025 Mar 24;14(4):307. doi: 10.3390/pathogens14040307.
  • Katsarou A, Stathopoulos P, Tzvetanova ID, Asimotou C-M, Falagas ME; β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development. Pathogens. 2025 Feb 8;14(2):168. doi: 10.3390/pathogens14020168.
  • Tansarli GS, Falagas ME, Fang FC; Clinical significance of toxin EIA positivity in patients with suspected Clostridioides difficile infection: systematic review and meta-analysis. J Clin Microbiol. 2025 Jan 31;63(1):e0097724. doi: 10.1128/jcm.00977-24.
  • Katsarou A, Tzikopoulou M, Papadopoulos D, Palioura S, Falagas ME; Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review. Expert Rev Anti Infect Ther. 2025 Jan;23(1):49-65. doi: 10.1080/14787210.2024.2448143.
  • Zhou H, et. Al.; Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. Multicenter Study J Antimicrob Chemother. 2024 Sep 3;79(9):2132-2141. doi: 10.1093/jac/dkae157.
  • Pérez-Galera S, et. al.; Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA). eClinical Medicine. 2023; 57:101871.
  • Giannos P, Kechagias KS, Katsikas Triantafyllidis K, Falagas ME; Spotlight on early Covid-19 research productivity: A 1-Year Bibliometric Analysis. Front Public Health. 2022;10:811885.
  • Tsegka KG, Voulgaris GL, Kyriakidou M, Kapaskelis A, Falagas ME; Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review. Expert Rev Anti Infect Ther. 2022;20:33-43.
  • Falagas ME, Kyriakidou M, Voulgaris GL, Vokos F, Politi S, Kechagias KS; Clinical use of intravenous polymyxin B for the treatment of patients with multidrug-resistant Gram-negative bacterial infections: An evaluation of the current evidence. J Glob Antimicrob Resist. 2021;24:342-359.
  • Rafailidis PI, Falagas ME; Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives. Expert Rev Anti Infect Ther. 2020;18:957-966.
  • Athanasiou S, Pitsouni E, Antonopoulou S, Zacharakis D, Salvatore S, Falagas ME, Grigoriadis T; Response letter to comments related to "The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women". Neurourol Urodyn. 2020 Mar;39(3):1026-1027.doi: 10.1002/nau.24315.
  • Kechagias KS, Chorepsima S, Triarides NA, Falagas ME; Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence. Eur J Clin Microbiol Infect Dis. 2020;39:1053-1058.
  • Rafailidis PI, Falagas ME; Addressing clinical safety of antimicrobial resistance: personal perspectives. Expert Rev Anti Infect Ther. 2019 Nov;17(11):865-869. doi: 10.1080/14787210.2019.1687294.
  • Symeonidis EN, Falagas ME, Dimitriadis F; Urinary tract infections in patients undergoing radical cystectomy and urinary diversion: challenges and considerations in antibiotic prophylaxis. Transl Androl Urol. 2019;8:286-289.
  • Vardakas KZ, Kyriakidou M, Apiranthiti KN, Almpani SE, Heliou D, Stratigopoulou D, Giourmetaki E, Lamprou D, Binou G, Mpaltzoglou E, Falagas ME; Trends of mortality in Greece prior to and during its current financial crisis (2009-2015). Rambam Maimonides Med J. 2019;doi:10.5041.
  • Voulgaris GL, Voulgari ML, Falagas ME; Developments on antibiotics for multidrug resistant bacterial Gram-negative infections. Expert Rev Anti Infect Ther. 2019;17:387-401.
  • Falagas ME, Voulgaris GL, Tryfinopoulou K, Giakkoupi P, Kyriakidou M, Vatopoulos A, Coates A, Hu Y; Colistin - Azidothymidine Hellenic Study Group. Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals. Int J Antimicrob Agents. 2019 Mar 2. pii: S0924-8579(19)30051-2. doi: 10.1016/j.ijantimicag.2019.02.021.
  • Vardakas KZ, Athanassaki F, Pitiriga V, Falagas ME. The clinical relevance of in vitro synergistic activity of antibiotics for MDR Gram-negative infections: A systematic review. J Glob Antimicrob Resist. 2019 Jan 15. pii: S2213-7165(19)30011-6. doi: 10.1016/j.jgar.2019.01.004.
  • Mavros MN, Theochari NA, Kyriakidou M, Economopoulos KP, Sava JA, Falagas ME. Fluoroquinolone-based versus beta lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomized controlled trials. Int J Antimicrob Agents. 2019 Jan 10. pii: S0924-8579(19)30004-4. doi: 10.1016/j.ijantimicag.2019.01.004.
  • Chorepsima S, Kechagias KS, Kalimeris G, Triarides NA, Falagas ME. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis. Drug Des Devel Ther. 2018;12:4059-4066.
  • Theocharis G, Kechagias KS, Oikonomou M, Chorepsima S, Rodis D, Salpigktis I, Falagas ME. A Model for Out-of-Hospital Multispecialty Emergency Medicine: Accomplishments and Challenges. Health Serv Insights. 2018;11:1178632918805996.
  • Falagas ME, Athanasaki F, Voulgaris GL, Triarides NA, Vardakas KZ. Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences. Int J Antimicrob Agents. 2019;53:22-28.
  • Athanasiou S, Pitsouni E, Grigoriadis T, Zacharakis D, Falagas ME, Salvatore S, Protopapas A, Loutradis D. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results. Menopause. 2019;26:248-255.
  • Pitsouni E, Grigoriadis T, Douskos A, Kyriakidou M, Falagas ME, Athanasiou S. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2018;229:45-56.
  • Dandoulakis M, Mavroudis AD, Karagianni A, Stefani S, Falagas ME. An analysis of medical visits at a primary health care center in Kinshasa, Democratic Republic of the Congo (DRC). Eur J Intern Med. 2018;53:e19-e20.
  • Theocharis G, Barbas SG, Spiropoulos T, Stamouli PE, Perdikis DN, Falagas ME. Patient house calls in Attica and Thessaloniki, Greece (2005-2015): a model for out-of-hospital multispecialty emergency medicine. BMC Health Serv Res. 2018;18(1):304.
  • Vardakas KZ, Kalimeris GD, Triarides NA, Falagas ME. An update on adverse drug reactions related to β-lactam antibiotics. Expert Opin Drug Saf. 2018;17(5):499-508.
  • Falagas ME, Skalidis T, Vardakas KZ, Voulgaris GL, Papanikolaou G, Legakis N; Hellenic TP-6076Study Group. Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals. Int J Antimicrob Agents. 2018. pii: S0924-8579(18)30080-3.
  • Falagas ME, Kyriakidou M, Spais G, Argiti E, Vardakas KZ.Temporal Trends (1999-2015) in the Impact Factor of Biomedical Journals Published by US and EU Scientific Societies. Rambam Maimonides Med J. 2018; 6:1-5.
  • Vardakas KZ, Mavroudis AD, Georgiou M, Falagas ME. Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis. J Infect. 2018;. pii: S0163-4453(18)30054-9.
  • Papst L, Beović B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M; ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.Clin Microbiol Infect. 2018; pii: S1198-743X(18)30069-7.
  • Vardakas KZ, Mavroudis AD, Georgiou M, Falagas ME. Intravenous colistin combination antimicrobial treatment vs.monotherapy: a systematic review and meta-analysis. Int J Antimicrob Agents. 2018;51:535-547.
  • Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis. 2018;18:108-120.
  • Vardakas KZ, Trigkidis KK, Apiranthiti KN, Falagas ME. The dilemma of monotherapy or combination therapy in community acquired pneumonia. Eur J Clin Invest. 2017;10.1111
  • Athanasiou S, Pitsouni E, Falagas ME, Salvatore S, Grigoriadis T. Maturitas, CO2-laser for the genitourinary syndrome of menopause. How many laser sessions? 2017;104:24-28.
  • Pitsouni E, Grigoriadis T, Falagas ME, Salvatore S, Athanasiou S. Maturitas. , Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis. 2017;103:78-88.
  • Samonis G, Vardakas KZ, Maraki S, Stamouli P, Mavromanolaki VE, Kofteridis DP, Falagas ME, Resistance phenotypes and susceptibility of contemporary Serratia isolates in the university hospital of Crete, Greece. Infect Dis (Lond). 2017;49(11-12):847-853.
  • Vardakas KZ, Voulgaris GL, Samonis G, Falagas ME, Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis, Int J Antimicrob Agents. 2017. pii: S0924-8579(17)30232-7.
  • Maraki S, Vardakas KZ, Samonis G, Perdikis D, Mavromanolaki VE, Kofteridis DP, Falagas ME, In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece, Future Microbiol. 2017;12:683-693.
  • Vamvakidis K, Rellos K, Tsourma M, Christoforides C, Anastasiou E, Zorbas KA, Arambatzi A, Falagas ME., Antibiotic prophylaxis for clean neck surgery., Ann R Coll Surg Engl. 2017 May;99(5):410-412.
  • Falagas ME, Vardakas KZ., Continuous or Extended Intravenous Administration of β-Lactam Antibiotics., Am J Respir Crit Care Med. 2017 Apr 15;195(8):1077-1078.
  • Falagas ME, Skalidis T, Vardakas KZ, Legakis NJ; Hellenic Cefiderocol Study Group., Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals., J Antimicrob Chemother. 2017 Mar 22.
  • Skalidis T, Papaparaskevas J, Konstantinou D, Kapolou E, Falagas ME, Legakis N., Aerococcus urinae, a cause of cystitis with malodorous urine in a child: clinical and microbiological challenges., JMM Case Rep. 2017 Feb 28;4(2):e005083.
  • Maraki S, Vardakas KZ, Mavromanolaki VE, Kyriakidou M, Spais G, Kofteridis DP, Samonis G, Falagas ME., In vitro susceptibility and resistance phenotypes in contemporary Citrobacter isolates in a University Hospital in Crete, Greece., Infect Dis (Lond). 2017 Jul;49(7):532-539.
  • Falagas ME, Georgiou M., Early investigational antibiotics for the treatment of acute exacerbations of chronic bronchitis., Expert Opin Investig Drugs. 2017 Mar;26(3):313-317
  • Vardakas KZ, Trigkidis KK, Falagas ME., Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis., Clin Microbiol Infect. 2017 Apr;23(4):234-241.
  • Gkegkes ID, Iavazzo C, Sardi TA, Falagas ME., Women Physicians in Byzantium., World J Surg. 2017 Mar;41(3):892-895
  • Vardakas KZ, Rellos K, Triarides NA, Falagas ME. Colistin loading dose: evaluation of the published pharmacokinetic and clinical data. Int J Antimicrob Agents. 2016 Sep 28, 48(5):475-484
  • Tansarli GS, Skalidis T, Legakis NJ, Falagas ME. Abnormal vaginal flora in symptomatic non-pregnant and pregnant women in a Greek hospital: a prospective study. Eur J Clin Microbiol Infect Dis. 2016 Oct, 48(5):475-484
  • Vardakas KZ, Falagas ME. Colistin versus polymyxin B for the treatment of patients with multi-drug resistant Gram-negative infections: a systematic review and meta-analysis. Int J Antimicrob Agents 2016 Sep, 47(4):269-85
  • Athanasiou S, Pitsouni E, Antonopoulou S, Zacharakis D, Salvatore S, Falagas ME, Grigoriadis T. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric. 2016 Oct, 19(5):512-8
  • Konstantelias AA, Polyzos KA, Falagas ME. Gentamicin-collagen sponges for the prevention of surgical site infections: a meta-analysis of ramdomised controlled trials. Surg Infect (Larchmt). 2016 Oct, 17(5):601-9
  • Falagas ME, Mavroudis AD, Vardakas KZ. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect? Expert Rev Anti Infect Ther. 2016 Aug, 14(8):747-63
  • Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. Int J Antimicrob Agents 2016 Jul, 48(1):1-10
  • Vardakas KZ, Theocharis G, Tansarli GS, Rafailidis P, Falagas ME. Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study. Arch Virol 2016 Sep, 161(9):2511-8
  • Vardakas KZ, Legakis NJ, Triarides N, Falagas ME. Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature. Int J Antimicrob Agents, 2016 Apr, 47(4):269-85
  • Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ. Fosfomycin. Clin Microbiol Rev, 2016 Apr, 29(2):321-47
  • Polyzos KA, Konstantelias AA, Pitsa CE, Falagas ME. Maternal Influenza Vaccination and Risk for Congenital Malformations: A Systematic Review and Meta-analysis. Obstet Gynecol, 2015 Nov, 126(5):1075-84
  • Kelesidis T, Falagas ME. The safety of polymyxin antibiotics. Expert Opin Drug Saf, 2015, 14(11):1687-701
  • Vardakas KZ, Anifantaki FI, Trigkidis KK, Falagas ME. Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes. Eur J Clin Microbiol Infect Dis, 2015 Nov, 34(11):2149-60
  • Makris GC, Trigkidis KK, Apiranthiti K, Malietzis G, Alexiou VG, Falagas ME. Medical training in Greece: A crisis in progress. Postgrad Med, 2015 Aug, 127(6):591-9
  • Falagas ME, Vardakas KZ, Roussos NS. Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence. Int J Antimicrob Agents, 2015 Sep, 46(3):231-41
  • Falagas ME, Rafailidis PI. Editorial Commentary: Fosfomycin: The Current Status of the Drug. Clin Infect Dis, 2015 Oct 1, 61(7):1144-6
  • Samonis G, Vardakas KZ, Tansarli GS, Dimopoulou D, Papadimitriou G, Kofteridis DP, Maraki S, Karanika M, Falagas ME. Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease. Epidemiol Infect, 2016 Jan, 144(1):161-70
  • Vardakas KZ, Matthaiou DK, Falagas ME, Antypa E, Koteli A, Antoniadou E. Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. Infect Dis (Lond), 2015, 47(10):751-3.
  • Zhang X, Falagas ME, Vardakas KZ, Wang R, Qin R, Wang J, Liu Y. Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis. J Thorac Dis. , 2015 Apr, 7(4):603-15
  • Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17:767-77
  • Falagas ME, Vardakas KZ, Kapaskelis A, Triarides NA, Roussos NS. Tetracyclines for multidrug-resistant Acinetobacter baumannii infections. Int J Antimicrob Agents. 2015 Feb 16. [Epub ahead of print].
  • Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015;28:443-64.
  • Konstantelias AA, Vardakas KZ, Polyzos KA, Tansarli GS, Falagas ME. Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis. J Neurosurg. 2015 Mar 13:1-17. [Epub ahead of print].
  • Bassetti M, Falagas ME, Kollef M. en old antibiotics that will never disappear. Intensive Care Med. 2015 Feb 25. [Epub ahead of print].
  • Falagas ME, Karagiannis AK, Nakouti T, Tansarli GS. Compliance with Once-Daily versus Twice or Thrice-Daily Administration of Antibiotic Regimens: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2015;10:e0116207.
  • Falagas ME, Trigkidis KK, Vardakas KZ. Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review. Int J Antimicrob Agents. 2014 Nov 6. pii: S0924-8579(14)00329-X.
  • Vardakas KZ, Matthaiou DK, Falagas ME, Antypa E, Koteli A, Antoniadou E. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. J Infect. 2014 Nov 15. pii: S0163-4453(14)00347-8.
  • Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70:396-404.
  • Vardakas KZ, Apiranthiti KN, Falagas ME. Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: A systematic review and meta-analysis. Int J Antimicrob Agents. 2014;44:486-492.
  • Rafailidis PI, Falagas ME. Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2014;27:479-83.
  • Rajenderan S, Balaji V, Anandan S, Sahni RD, Tansarli GS, Falagas ME. Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study. PLoS One. 2014;9:e103253.
  • Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20:1170-5.
  • Samonis G, Vardakas KZ, Kofteridis DP, Dimopoulou D, Andrianaki AM, Chatzinikolaou I, Katsanevaki E, Maraki S, Falagas ME. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Infection. 2014;42:721-8.
  • Kostaras EK, Tansarli GS, Falagas ME. Use of negative-pressure wound therapy in breast tissues: evaluation of the literature. Surg Infect (Larchmt). 2014;15:679-85.
  • Poulikakos P, Tansarli GS, Falagas ME. Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Eur J Clin Microbiol Infect Dis. 2014;33:1675-85.
  • Tansarli GS, Vardakas KZ, Stratoulias C, Peppas G, Kapaskelis A, Falagas ME. Vacuum-assisted closure versus closure without vacuum assistance for preventing surgical site infections and infections of chronic wounds: a meta-analysis of randomized controlled trials. Surg Infect (Larchmt). 2014;15:363-7.
  • Samonis G, Korbila IP, Maraki S, Michailidou I, Vardakas KZ, Kofteridis D, Dimopoulou D, Gkogkozotou VK, Falagas ME. Eur J Clin Microbiol Infect Dis. 2014;33:1505-10.
  • Plessa E, Tansarli GS, Xanthopoulos D, Falagas ME. Morbidity and outcomes of foreign travelers in Zakynthos island, Greece: a retrospective study. PLoS One. 2014;9:e94416.
  • Falagas ME, Vardakas KZ, Tsiveriotis KP, Triarides NA, Tansarli GS. Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections. Int J Antimicrob Agents. 2014;44:1-7.
  • Xu-hong Y, Falagas ME, Dong W, Karageorgopoulos DE, De-feng L, Rui W. In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo). 2014;67:369-71.
  • Kostaras EK, Tansarli GS, Falagas ME. Use of Negative-Pressure Wound Therapy in Breast Tissues: Evaluation of the Literature. Surg Infect (Larchmt). 2014 May 28. [Epub ahead of print] PubMed PMID: 24871230.
  • Samonis G, Vardakas KZ, Kofteridis DP, Dimopoulou D, Andrianaki AM, Chatzinikolaou I, Katsanevaki E, Maraki S, Falagas ME. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Infection. 2014 Jun 10. [Epub ahead of print] PubMed PMID: 24912861.
  • Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant enterobacteriaceae infections. Emerg Infect Dis. 2014;20:1170-5.
  • Tansarli GS, Poulikakos P, Kapaskelis A, Falagas ME. Proportion of extended-spectrum β-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence--systematic review. J Antimicrob Chemother. 2014;69:1177-84.
  • Xu-Hong Y, Falagas ME, Dong W, Karageorgopoulos DE, De-Feng L, Rui W. In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo). 2014;67:69-71.
  • Falagas ME, Vardakas KZ, Tsiveriotis KP, Triarides NA, Tansarli GS. Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections. Int J Antimicrob Agents. 2014 Feb 6.
  • Plessa E, Tansarli GS, Xanthopoulos D, Falagas ME. Morbidity and outcomes of foreign travelers in zakynthos island, Greece: a retrospective study. PLoS One. 2014;9:e94416.
  • Samonis G, Korbila IP, Maraki S, Michailidou I, Vardakas KZ, Kofteridis D, Dimopoulou D, Gkogkozotou VK, Falagas ME. Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital. Eur J Clin Microbiol Infect Dis. 2014 Apr 15. [Epub ahead of print].
  • Tansarli GS, Vardakas KZ, Stratoulias C, Peppas G, Kapaskelis A, Falagas ME. Vacuum-Assisted Closure versus Closure without Vacuum Assistance for Preventing Surgical Site Infections and Infections of Chronic Wounds: A Meta-Analysis of Randomized Controlled Trials. Surg Infect (Larchmt). 2014 May 8. [Epub ahead of print].
  • Poulikakos P, Tansarli GS, Falagas ME. Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Eur J Clin Microbiol Infect Dis. 2014 May 16. [Epub ahead of print].
  • Kostaras EK, Tansarli GS, Falagas ME. Use of Negative-Pressure Wound Therapy in Breast Tissues: Evaluation of the Literature. Surg Infect (Larchmt). 2014 May 28. [Epub ahead of print].
  • Falagas ME, Karageorgopoulos DE, Tansarli GS. Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis. PLoS One. 2013 Oct 21;8(10):e77075.
  • Fysaraki M, Samonis G, Valachis A, Daphnis E, Karageorgopoulos DE, Falagas ME, Stylianou K, Kofteridis DP. Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci. 2013 Sep 20;10(12):1632-8.
  • Zarkali A, Karageorgopoulos DE, Rafailidis PI, Falagas ME. Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature. Curr Med Res Opin. 2013 Nov 12.
  • Michalopoulos AS, Falagas ME. Inhaled antibiotics in mechanically ventilated patients. Minerva Anestesiol. 2013 Oct 9.
  • Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother. 2013 Sep 30.
  • Falagas ME, Karageorgopoulos DE, Leptidis J, Korbila IP. MRSA in Africa: filling the global map of antimicrobial resistance. PLoS One. 2013 Jul 29;8(7):e68024.
  • Falagas ME, Korbila IP, Kapaskelis A, Manousou K, Leontiou L, Tansarli GS. Trends of mortality due to septicemia in Greece: an 8-year analysis. PLoS One. 2013 Jul 2;8(7):e67621.
  • Korbila IP, Tansarli GS, Karageorgopoulos DE, Vardakas KZ, Falagas ME. Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis. Expert Rev Anti Infect Ther. 2013 Jun;11(6):585-95.
  • Poulikakos P, Falagas ME. Aminoglycoside therapy in infectious diseases. Expert Opin Pharmacother. 2013 Aug;14(12):1585-97.
  • Falagas ME, Tansarli GS, Kapaskelis A, Vardakas KZ. Impact of vacuum-assisted closure (VAC) therapy on clinical outcomes of patients with sternal wound infections: a meta-analysis of non-randomized studies. PLoS One. 2013 May 31;8(5):e64741.
  • Tansarli GS, Athanasiou S, Falagas ME. Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa. Antimicrob Agents Chemother. 2013 Aug;57(8):3628-39.
  • Karageorgopoulos DE, Maraki S, Vatopoulos AC, Samonis G, Schito GC, Falagas ME. Antimicrobial activity of prulifloxacin in comparison with other fluoroquinolones against community-acquired urinary and respiratory pathogens isolated in Greece. Eur J Clin Microbiol Infect Dis. 2013 Nov;32(11):1417-22.
  • Sahni RD, Balaji V, Varghese R, John J, Tansarli GS, Falagas ME. Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: a prospective study. Future Microbiol. 2013 May;8(5):675-80.
  • Samonis G, Vardakas KZ, Maraki S, Tansarli GS, Dimopoulou D, Kofteridis DP, Andrianaki AM, Falagas ME. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer. 2013 Sep;21(9):2521-6.
  • Tansarli GS, Karageorgopoulos DE, Kapaskelis A, Gkegkes I, Falagas ME. Iron deficiency and susceptibility to infections: evaluation of the clinical evidence. Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1253-8.
  • Tansarli GS, Rafailidis PI, Papazoglou AA, Falagas ME. Antimicrobial activity and clinical effectiveness of sisomicin: an evaluation of the literature (1995-2011). Expert Rev Anti Infect Ther. 2013 Apr;11(4):421-8.
  • Falagas ME, Tansarli GS, Ikawa K, Vardakas KZ. Reply to Soman et al and Frippiat et al. Clin Infect Dis. 2013 Jul;57(2):325-7.
  • Theocharis G, Tansarli GS, Mavros MN, Spiropoulos T, Barbas SG, Falagas ME. Association between use of air-conditioning or fan and survival of elderly febrile patients: a prospective study. Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1143-7.
  • Tansarli GS, Karageorgopoulos DE, Kapaskelis A, Falagas ME. Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Expert Rev Anti Infect Ther. 2013 Mar;11(3):321-31.
  • Tansarli GS, Kostaras EK, Athanasiou S, Falagas ME. Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur J Clin Microbiol Infect Dis. 2013 Aug;32(8):977-84.
  • Falagas ME, Tansarli GS, Kapaskelis A, Vardakas KZ. Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review. Expert Rev Anti Infect Ther. 2013 Jan;11(1):69-78.
  • Vardakas KZ, Tansarli GS, Bliziotis IA, Falagas ME. â-Lactam plus aminoglycoside or fluoroquinolone combination versus â-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. Int J Antimicrob Agents. 2013 Apr;41(4):301-10.
  • Falagas ME, Zarkali A, Karageorgopoulos DE, Bardakas V, Mavros MN. The impact of article length on the number of future citations: a bibliometric analysis of general medicine journals. PLoS One. 2013;8(2):e49476.
  • Mavros MN, Mitsikostas PK, Alexiou VG, Peppas G, Falagas ME. Antimicrobials as an adjunct to pilonidal disease surgery: a systematic review of the literature. Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):851-8.
  • Cai Y, Chai D, Falagas ME, Karageorgopoulos DE, Wang R, Bai N, Liang B. Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study. Expert Opin Investig Drugs. 2013 Mar;22(3):309-15.
  • Vardakas KZ, Kontopidis I, Gkegkes ID, Rafailidis PI, Falagas ME. Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review. Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):711-21.
  • Mavros MN, Alexiou VG, Vardakas KZ, Falagas ME. Understanding of statistical terms routinely used in meta-analyses: an international survey among researchers. PLoS One. 2013;8(1):e47229.
  • Tansarli GS, Rafailidis PI, Kapaskelis A, Falagas ME. Frequency of the off-label use of antibiotics in clinical practice: a systematic review. Expert Rev Anti Infect Ther. 2012;10:1383-92.
  • Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug? J Infect. 2012 Nov 6. [Epub ahead of print].
  • Falagas ME, Tansarli GS, Ikawa K, Vardakas KZ. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis. 2012 Oct 16. [Epub ahead of print].
  • Mavros MN, Tansarli GS, Vardakas KZ, Rafailidis PI, Karageorgopoulos DE, Falagas ME. Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. Int J Antimicrob Agents. 2012 Oct 12. pii: S0924-8579(12)00341-X. [Epub ahead of print]
  • Pergialiotis V, Arnos P, Mavros MN, Pitsouni E, Athanasiou S, Falagas ME. Urinary tract analgesics for the treatment of patients with acute cystitis: where is the clinical evidence? Expert Rev Anti Infect Ther. 2012;10:875-9.
  • Maraki S, Mavros MN, Kofteridis DP, Samonis G, Falagas ME. Epidemiology and Antimicrobial Sensitivities of 536 Multi-Drug-Resistant Gram-Negative Bacilli Isolated from Patients Treated on Surgical Wards. Surg Infect (Larchmt). 2012 Sep 26. [Epub ahead of print].
  • Mavros MN, Alexiou VG, Vardakas KZ, Tsokali K, Sardi TA, Falagas ME. Erratum to: Underestimation of Clostridium difficile infection among clinicians: an international survey. Eur J Clin Microbiol Infect Dis. 2012;31:2863-4.
  • Vardakas KZ, Konstantelias AA, Loizidis G, Rafailidis PI, Falagas ME. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. Int J Infect Dis. 2012 Aug 22. [Epub ahead of print].
  • Polyzos KA, Mavros MN, Vardakas KZ, Makris MC, Rafailidis PI, Falagas ME. Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis. PLoS One. 2012;7:e41870.
  • Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum â-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother. 2012 Aug 21. [Epub ahead of print].
  • Spanos A, Theocharis G, Karageorgopoulos DE, Peppas G, Fouskakis D, Falagas ME. Surveillance of community outbreaks of respiratory tract infections based on house-call visits in the metropolitan area of Athens, Greece. PLoS One. 2012;7:e40310.
  • Falagas ME, Rafailidis PI. Colistin in ventilator-associated pneumonia. Clin Infect Dis. 2012;54:681-3.
  • Theocharis G, Polyzos KA, Vouloumanou EK, Peppas G, Spiropoulos T, Barbas SG, Falagas ME. Morbidity of foreign travelers in Attica, Greece: a retrospective study. Eur J Clin Microbiol Infect Dis. 2012 Feb 2. [Epub ahead of print].
  • Cai Y, Chai D, Falagas ME, Vouloumanou EK, Wang R, Guo D, Bai N, Liang B, Liu Y. Immediate hematological toxicity of linezolid in healthy volunteers with different body weight: a phase I clinical trial. J Antibiot (Tokyo). 2012 Jan 25. doi: 10.1038/ja.2011.142. [Epub ahead of print].
  • Theocharis G, Mavros MN, Vouloumanou EK, Peppas G, Barbas SG, Spiropoulos T, Falagas ME. Comparison of morbidity of elderly patients in August and November in Attica, Greece: a prospective study. Int J Clin Pract. 2012;66:84-90.
  • Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Makris MC, Polyzos KA, Mavros MN, Athanasiou S, Rafailidis PI, Falagas ME. Drug Saf. 2012;35:1-14.
  • Karageorgopoulos DE, Wang R, Yu XH, Falagas ME. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother. 2011 Nov 16. [Epub ahead of print].
  • Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs. 2011;71:2277-94.
  • Bliziotis IA, Petrosillo N, Michalopoulos A, Samonis G, Falagas ME. Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia. PLoS One. 2011;6:e26470.
  • Samonis G, Koutsounaki E, Karageorgopoulos DE, Mitsikostas P, Kalpadaki C, Bozionelou V, Bompolaki I, Sgouros J, Taktikou V, Falagas ME. Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. Eur J Clin Microbiol Infect Dis. 2011 Oct 31. [Epub ahead of print].
  • Hatziagelaki E, Karageorgopoulos DE, Chounta A, Tsiavou A, Falagas ME, Dimitriadis G. Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease. Exp Diabetes Res. 2012;35:1974.
  • Iavazzo C, Gkegkes ID, Vouloumanou EK, Mamais I, Peppas G, Falagas ME. Sutures versus staples for the management of surgical wounds: a meta-analysis of randomized controlled trials. Am Surg. 2011;77:1206-21.
  • Gkegkes ID, Mavros MN, Alexiou VG, Peppas G, Athanasiou S, Falagas ME. Adhesive Strips for the Closure of Surgical Incisional Sites: A Systematic Review and Meta-Analysis. Surg Innov. 2011 Sep 16. [Epub ahead of print].
  • Mavros MN, Athanasiou S, Alexiou VG, Mitsikostas PK, Peppas G, Falagas ME. Risk factors for mesh-related infections after hernia repair surgery: a meta-analysis of cohort studies. World J Surg. 2011;35:2389-98.
  • Michalopoulos AS, Falagas ME. Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care. 2011;1:30.
  • Sideri G, Kafetzis DA, Vouloumanou EK, Papadatos JH, Papadimitriou M, Falagas ME. Ciprofloxacin in critically ill children. Anaesth Intensive Care. 2011;39:635-9.
  • Samonis G, Maraki S, Karageorgopoulos DE, Vouloumanou EK, Falagas ME. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis. 2011 Jul 31. [Epub ahead of print].
  • Alexiou VG, Michalopoulos A, Makris GC, Peppas G, Samonis G, Falagas ME. Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study. Eur J Clin Microbiol Infect Dis. 2011 Jul 28. [Epub ahead of print].
  • Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011 May 7. doi: 10.1111/j.1469-0691.2011.03570.x. [Epub ahead of print].
  • Sideri G, Falagas ME, Grigoriou M, Vouloumanou EK, Papadatos JH, Lebessi E, Kafetzis DA. Liposomal amphotericin B in critically ill paediatric patients. J Clin Pharm Ther. 2011 Jul 21. doi: 10.1111/j.1365-2710.2011.01288.x. [Epub ahead of print].
  • Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME. Boric Acid for Recurrent Vulvovaginal Candidiasis: The Clinical Evidence. J Womens Health (Larchmt). 2011 Jul 20. [Epub ahead of print].
  • Sun C, Falagas ME, Wang R, Karageorgopoulos DE, Yu X, Liu Y, Cai Y, Liang B, Song X, Liu Z. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo). 2011 Jul 20. doi: 10.1038/ja.2011.52. [Epub ahead of print].
  • Theocharis G, Vouloumanou EK, Barbas SG, Spiropoulos T, Rafailidis PI, Falagas ME. Comparison of characteristics of outpatients with 2009 H1N1 pandemic and seasonal influenza. Int J Clin Pract. 2011;65:871-8.
  • Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. Age Distribution of Cases of 2009 (H1N1) Pandemic Influenza in Comparison with Seasonal Influenza. PLoS One. 2011;6(7):e21690. Epub 2011 Jul 1.
  • Vouloumanou EK, Karageorgopoulos DE, Rafailidis PI, Michalopoulos A, Falagas ME. Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. Int J Antimicrob Agents. 2011 Jul 7. [Epub ahead of print].
  • Falagas ME, Karageorgopoulos DE, Nordmann P. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol. 2011;6:653-66.
  • Makris GC, Lavida A, Griffin M, Geroulakos G, Nicolaides AN. Three-dimensional ultrasound imaging for the evaluation of carotid atherosclerosis. Atherosclerosis. 2011 May 13. [Epub ahead of print].
  • Alexiou VG, Salazar-Salvia MS, Jervis PN, Falagas ME. Modern Technology-Assisted vs Conventional Tonsillectomy: A Meta-analysis of Randomized Controlled Trials. Arch Otolaryngol Head Neck Surg. 2011;137:558-70.
  • Mantadakis E, Vouloumanou EK, Georgantzi GG, Tsalkidis A, Chatzimichael A, Falagas ME. Acute Tc-99m DMSA Scan for Identifying Dilating Vesicoureteral Reflux in Children: A Meta-analysis. Pediatrics. 2011 Jun 13. [Epub ahead of print].
  • Agrafiotis M, Siempos II, Ntaidou TK, Falagas ME. Attributable mortality of ventilator-associated pneumonia: a meta-analysis. Int J Tuberc Lung Dis. 2011 Jun 8. [Epub ahead of print].
  • Mavros MN, Athanasiou S, Gkegkes ID, Polyzos KA, Peppas G, Falagas ME. Do psychological variables affect early surgical recovery? PLoS One. 2011;6:e20306.
  • Peppas G, Makris MC, Falagas ME. Biological mesh for abdominal wall hernia synthetic mesh multidrug-resistant Pseudomonas aeruginosa infection: report of a case. Surg Today. 2011;41:717-20.
  • Mavros MN, Velmahos GC, Falagas ME. Atelectasis as a cause of postoperative fever: Where is the clinical evidence? Chest. 2011 Apr 28. [Epub ahead of print]
  • Makris GC, Geroulakos G, Makris MC, Mikhailidis DP, Falagas ME. The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective. Expert Opin Investig Drugs. 2010;19:809-14.
  • Makris GC, Nicolaides AN, Geroulakos G. The Management of Asymptomatic Carotid Plaque Disease: Our Assumptions When We are Less Radical. Angiology. 2011 Feb 8. [Epub ahead of print].
  • Kwa AL, Falagas ME, Michalopoulos A, Tam VH. Benefits of aerosolized colistin for ventilator-associated pneumonia: absence of proof versus proof of absence? Clin Infect Dis. 2011;52:1278-9.
  • Koutzavekiaris I, Vouloumanou EK, Gourni M, Rafailidis PI, Michalopoulos A, Falagas ME. Knowledge and practices regarding prevention of infections associated with central venous catheters: A survey of intensive care unit medical and nursing staff. Am J Infect Control. 2011 Apr 14. [Epub ahead of print].
  • Falagas ME, Thomaidis PC, Kotsantis IK, Sgouros K, Samonis G, Karageorgopoulos DE. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect. 2011 Mar 8. [Epub ahead of print].
  • Karageorgopoulos DE, Lamnatou V, Sardi TA, Gkegkes ID, Falagas ME. Temporal trends in the impact factor of European versus USA biomedical journals. PLoS One. 2011;6:e16300.
  • Rafailidis PI, Polyzos KA, Sgouros K, Falagas ME. Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections. Int J Antimicrob Agents. 2011;37:283-90.
  • Makris GC, Nicolaides AN, Geroulakos G. Histological Analysis of the Carotid Plaque Post-endarterectomy: A Waste of Time or a Wasted Piece of Information? Eur J Vasc Endovasc Surg. 2011 Apr 15. [Epub ahead of print].
  • Michalopoulos A, Metaxas EI, Falagas ME. Aerosol Delivery of Antimicrobial Agents During Mechanical Ventilation: Current Practice and Perspectives. Curr Drug Deliv. 2011 Jan 14. [Epub ahead of print].
  • Samonis G, Vouloumanou EK, Christofaki M, Dimopoulou D, Maraki S, Triantafyllou E, Kofteridis DP, Falagas ME. Serratia infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis. 2011 Jan 10. [Epub ahead of print].
  • Peppas G, Gkegkes ID, Makris MC, Falagas ME. Biological mesh in hernia repair, abdominal wall defects, and reconstruction and treatment of pelvic organ prolapse: a review of the clinical evidence. Am Surg. 2010 Nov;76(11):1290-9.
  • Mavros MN, Polyzos KA, Rafailidis PI, Falagas ME. Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis. J Antimicrob Chemother. 2010 Dec 3. [Epub ahead of print].
  • Angelousi AG, Karageorgopoulos DE, Kapaskelis AM, Falagas ME. Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic review. Eur J Endocrinol. 2010 Nov 15. [Epub ahead of print].
  • Samonis G, Falagas ME, Lionakis S, Ntaoukakis M, Kofteridis DP, Ntalas I, Maraki S. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut. Med Mycol. 2010 Nov 15. [Epub ahead of print].
  • Michalopoulos A, Falagas ME, Karatza DC, Alexandropoulou P, Papadakis E, Gregorakos L, Chalevelakis G, Pappas G. Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am J Infect Control. 2010 Oct 28. [Epub ahead of print].
  • Falagas ME, Korbila IP, Karageorgopoulos DE. Probiotics for the prevention of ventilator-associated pneumonia. Expert Rev Respir Med. 2010;4:567-71.
  • Falagas ME, Koletsi PK, Baskouta E, Rafailidis PI, Dimopoulos G, Karageorgopoulos DE. Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience. Epidemiol Infect. 2010 Oct 5:1-14. [Epub ahead of print].
  • Falagas ME, Rafailidis PI, Matthaiou DK. Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist Updat. 2010 Jun 16. [Epub ahead of print].
  • Mavros MN, Mitsikostas PK, Kontopidis IG, Moris DN, Dimopoulos G, Falagas ME. H1N1v influenza vaccine in Greek medical students. Eur J Public Health. 2010 Sep 10. [Epub ahead of print].
  • Kondilis BK, Akrivos PD, Sardi TA, Soteriades ES, Falagas ME. Readability levels of health pamphlets distributed in hospitals and health centres in Athens, Greece. Public Health. 2010 Sep 9. [Epub ahead of print].
  • Theocharis G, Vouloumanou EK, Rafailidis PI, Spiropoulos T, Barbas SG, Falagas ME. Evaluation of a direct test for seasonal influenza in outpatients. Eur J Intern Med. 2010;21:434-8.
  • Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010 Aug 24. [Epub ahead of print].
  • Rafailidis PI, Mavros MN, Kapaskelis A, Falagas ME. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol. 2010 Aug 23. [Epub ahead of print].
  • Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Batsiou MA, Karageorgopoulos DE. Comparison of the distribution of citations received by articles published in high, moderate, and low impact factor journals in clinical medicine. Intern Med J. 2010;40:587-91.
  • Alexiou VG, Ierodiakonou V, Peppas G, Falagas ME. Antimicrobial prophylaxis in surgery: an international survey. Surg Infect (Larchmt). 2010;11:343-8.
  • Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Pediatr Pulmonol. 2010 Jul 23. [Epub ahead of print].
  • Falagas ME, Vouloumanou EK, Plessa E, Peppas G, Rafailidis PI. Inaccuracies in dosing drugs with teaspoons and tablespoons. Int J Clin Pract. 2010;64:1185-9.
  • Falagas ME, Cholevas NV, Kapaskelis AM, Vouloumanou EK, Michalopoulos A, Rafailidis PI. Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis. 2010 Jul 13. [Epub ahead of print].
  • Petrosillo N, Drapeau CM, Agrafiotis M, Falagas ME. Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care. Minerva Anestesiol. 2010;76:509-24.
  • Makris GC, Lavida A, Nicolaides AN, Geroulakos G. The effect of statins on carotid plaque morphology: A LDL-associated action or one more pleiotropic effect of statins? Atherosclerosis. 2010 May 7. [Epub ahead of print].
  • Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI, Athanasiou S. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010 Jun 29. [Epub ahead of print].
  • Petrosillo N, Drapeau CM, Agrafiotis M, Falagas ME. Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care. Minerva Anestesiol. 2010 Jun 11. [Epub ahead of print].
  • Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G, Falagas ME. Chronic bacterial and parasitic infections and cancer: a review. J Infect Dev Ctries. 2010;4:267-81.
  • Rafailidis PI, Bliziotis IA, Falagas ME. Case-Control Studies Reporting on Risk Factors for Emergence of Antimicrobial Resistance: Bias Associated with the Selection of the Control Group. Microb Drug Resist. 2010 Jun 7. [Epub ahead of print].
  • Mantadakis E, Tsalkidis A, Panopoulou M, Pagkalis S, Tripsianis G, Falagas M, Kartali-Ktenidou S, Chatzimichael A. Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece. Int Urol Nephrol. 2010 Jun 4. [Epub ahead of print].
  • Samonis G, Maraki S, Rafailidis PI, Kapaskelis A, Kastoris AC, Falagas ME. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials. Clin Pediatr (Phila). 2010 Jun 3. [Epub ahead of print].
  • Falagas ME, Kouranos VD, Athanassa Z, Kopterides P. Tuberculosis and malignancy. QJM. 2010 May 26. [Epub ahead of print].
  • Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Rello J. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010;65:1330-46.
  • Kakisi OK, Kechagia AS, Kakisis IK, Rafailidis PI, Falagas ME. Tuberculosis of the oral cavity: a systematic review. Eur J Oral Sci. 2010;118:103-9.
  • Samonis G, Matthaiou DK, Kofteridis D, Maraki S, Falagas ME. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in crete, Greece. Clin Infect Dis. 2010;50:1689-91.
  • Makris GC, Geroulakos G, Makris MC, Mikhailidis DP, Falagas ME. The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective. Expert Opin Investig Drugs. 2010 May 15. [Epub ahead of print].
  • Falagas ME, Bliziotis IA, Kosmidis J, Daikos GK. Unusual climatic conditions and infectious diseases: observations made by Hippocrates. Enferm Infecc Microbiol Clin. 2010 May 11. [Epub ahead of print].
  • Falagas ME, Vouloumanou EK, Sgouros K, Athanasiou S, Peppas G, Siempos II. Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents. Int J Antimicrob Agents. 2010 May 10. [Epub ahead of print].
  • Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Kapaskelis A, Samonis G. Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin. Int J Antimicrob Agents. 2010;35:497-9.
  • Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin Pharmacother. 2010;11:779-88.
  • Agrafiotis M, Siempos II, Falagas ME. Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir Med. 2010;104:325-36.
  • Kastoris AC, Rafailidis PI, Vouloumanou EK, Gkegkes ID, Falagas ME. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Eur J Clin Pharmacol. 2010 Feb 26. [Epub ahead of print]
  • Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents. 2010 Feb 23. [Epub ahead of print]
  • Makris GC, Makris MC, Wilmot VV, Geroulakos G, Falagas ME. The Role of Infection in Carotid Plaque Pathogenesis and Stability: The Clinical Evidence. Curr Vasc Pharmacol. 2010 Feb 25. [Epub ahead of print]
  • Agrafiotis M, Siempos II, Falagas ME. Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: Systematic review and meta-analysis. Respir Med. 2010 Feb 15. [Epub ahead of print]
  • Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010;10:43-50.
  • Siempos II, Kopterides P, Tsangaris I, Dimopoulou I, Armaganidis AE. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med. 2009;37:2283-9.
  • Varbobitis IC, Pappas G, Karageorgopoulos DE, Anagnostopoulos I, Falagas ME. Decreasing trends of ultrasonographic prevalence of cystic echinococcosis in a rural Greek area. Eur J Clin Microbiol Infect Dis. 2010 Jan 21. [Epub ahead of print]
  • Falagas ME, Kouranos VD, Michalopoulos A, Rodopoulou SP, Athanasoulia AP, Karageorgopoulos DE. Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences. Clin Infect Dis. 2010;50:468-72.
  • Falagas ME, Karamanidou C, Kastoris AC, Karlis G, Rafailidis PI. Psychosocial factors and susceptibility to or outcome of acute respiratory tract infections. Int J Tuberc Lung Dis. 2010;14:141-8.
  • Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Mavromanolakis E, Samonis G. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents. 2009 Dec 22. [Epub ahead of print].
  • Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. Crit Care Med. 2009 Dec 15. [Epub ahead of print].
  • Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents. . [Epub ahead of print].
  • Karageorgopoulos DE, Falagas ME. New antibiotics: optimal use in current clinical practice. Int J Antimicrob Agents. 2009;34 Suppl 4:S55-62.
  • Falagas ME, Akrivos PD, Alexiou VG, Saridakis V, Moutos T, Peppas G, Kondilis BK. Patients' perception of quality of pre-operative informed consent in athens, Greece: a pilot study. PLoS One. 2009;4:e8073.
  • Siempos II, Vardakas KZ, Kyriakopoulos CE, Ntaidou TK, Falagas ME. Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis. Shock. 2009 Nov 26. [Epub ahead of print].
  • Pappas G, Papadimitriou P, Kontogiannis KE, Falagas ME. A World Wide Web Guide to Pediatric Infectious Diseases. J Trop Pediatr. 2009 Nov 30. [Epub ahead of print].
  • Makris GC, Spanos A, Rafailidis PI, Falagas ME. Increasing contribution of China in modern biomedical research. Statistical data from ISI Web of Knowledge. Med Sci Monit. 2009;15:SR15-21.
  • Falagas ME, Michalopoulos A, Metaxas EI. Pulmonary drug delivery systems for antimicrobial agents: facts and myths. Int J Antimicrob Agents. 2009 Nov 23. [Epub ahead of print].
  • Bliziotis IA, Plessa E, Peppas G, Falagas ME. Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis (January). Ann Pharmacother. 2009 Nov 24. [Epub ahead of print].
  • Iavazzo CR, Trompoukis C, Siempos II, Falagas ME. The breast: from Ancient Greek myths to Hippocrates and Galen. Reprod Biomed Online. 2009;19 Suppl 2:51-4.
  • Vardakas KZ, Matthaiou DK, Falagas ME. Comparison of community-acquired pneumonia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus producing the Panton-Valentine leukocidin. Int J Tuberc Lung Dis. 2009;13:1476-1485.
  • Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol. 2009;4:1103-9.
  • Falagas ME, Karageorgopoulos DE. Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet. 2009 Oct 27. [Epub ahead of print].
  • http://www.ncbi.nlm.nih.gov/pubmed/19850301?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=5Mantadakis E, Plessa E, Vouloumanou EK, Karageorgopoulos DE, Chatzimichael A, Falagas ME. Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies. J Pediatr. 2009;155:875-881.e1.
  • Falagas ME, Makris GC, Karageorgopoulos DE, Batsiou M, Alexiou VG. How well do clinical researchers understand risk estimates? Epidemiology. 2009;20:930-1.
  • Roussos N, Karageorgopoulos DE, Samonis G, Falagas ME. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents. 2009;34:506-15.
  • Alexiou VG, Ierodiakonou V, Dimopoulos G, Falagas ME. Re: Semirecumbent position to prevent ventilator-associated pneumonia is not evidence based. J Crit Care. 2009 Oct 12. [Epub ahead of print].
  • Moutzouris DA, Falagas ME. Interstitial Cystitis: An Unsolved Enigma. Clin J Am Soc Nephrol. 2009 Oct 1. [Epub ahead of print].
  • Falagas ME, Metaxas EI. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization. Expert Rev Anti Infect Ther. 2009;7:913-23.
  • Falagas ME, Karageorgopoulos DE, Moraitis LI, Vouloumanou EK, Roussos N, Peppas G, Rafailidis PI. Seasonality of mortality: the September phenomenon in Mediterranean countries. CMAJ. 2009 Sep 21. [Epub ahead of print].
  • Korbila IP, Michalopoulos A, Rafailidis PI, Nikita D, Samonis G, Falagas ME. Inhaled colistin as adjunctive to intravenous colistin for the treatment of microbiologically documented VAP: a comparative cohort study. Clin Microbiol Infect. 2009 Sep 2. [Epub ahead of print].
  • Kakisi OK, Grammatikos AA, Karageorgopoulos DE, Athanasoulia AP, Papadopoulou AV, Falagas ME. Prevalence of hepatitis B, hepatitis C, and HIV infections among patients in a psychiatric hospital in Greece. Psychiatr Serv. 2009;60:1269-72.
  • Falagas ME, Korbila IP, Giannopoulou KP, Kondilis BK, Peppas G. Informed consent: how much and what do patients understand? Am J Surg. 2009;198:420-35.
  • Vardavas CI, Kondilis BK, Patelarou E, Akrivos PD, Falagas ME. Health literacy and sources of health education among adolescents in Greece. Int J Adolesc Med Health. 2009;21:179-86.
  • Pappas G, Ierodiakonou V, Falagas ME. Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe. Clin Ther. 2009;31:1595-603.
  • Michalopoulos A, Virtzili S, Rafailidis P, Chalevelakis G, Damala M, Falagas ME. Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clin Microbiol Infect. 2009 Aug 20. [Epub ahead of print].
  • Falagas ME, Alexiou VG, Peppas G, Makris GC. Do Changes in Antimicrobial Resistance Necessitate Reconsideration of Surgical Antimicrobial Prophylaxis Strategies? Surg Infect (Larchmt). 2009 Aug 18. [Epub ahead of print].
  • Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME. Antimicrobial susceptibility of urinary bacteria to fosfomycin. Antimicrob Agents Chemother. 2009 Aug 17. [Epub ahead of print].
  • Dimopoulos G, Falagas ME. Approach to the febrile patient in the ICU. Infect Dis Clin North Am. 2009;23:471-84.
  • Kouranos VD, Karageorgopoulos DE, Peppas G, Falagas ME. Comparison of adverse events between oral and intravenous formulations of antimicrobial agents: a systematic review of the evidence from randomized trials. Pharmacoepidemiol Drug Saf. 2009 Aug 3. [Epub ahead of print].
  • Karageorgopoulos DE, Valkimadi PE, Kapaskelis A, Rafailidis PI, Falagas ME. Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children. Arch Dis Child. 2009;94:607-14.
  • Falagas ME, Vouloumanou EK, Mavros MN, Karageorgopoulos DE. Economic crises and mortality: a review of the literature. Int J Clin Pract. 2009;63:1128-35.
  • Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect. 2009 Jul 9. [Epub ahead of print].
  • Falagas ME, Kapaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs. 2009;69:1351-61.
  • Samonis G, Giannousi Z, Varbobitis IC, Sardi TA, Falagas ME. Family support of elderly patients hospitalized in a public tertiary hospital in Greece: a prospective study. J Am Geriatr Soc. 2009;57:1302-4.
  • Falagas ME, Zarkadoulia E, Rafailidis PI. The therapeutic effect of balneotherapy: evaluation of the evidence from randomised controlled trials. Int J Clin Pract. 2009;63:1068-84.
  • Pappas G, Saplaoura K, Falagas ME. Current treatment of pseudomonal infections in the elderly. Drugs Aging. 2009;26:363-79.
  • Falagas ME, Roussos N, Gkegkes ID, Rafailidis PI, Karageorgopoulos DE. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin Investig Drugs. 2009;18:921-44.
  • Vardakas KZ, Matthaiou DK, Falagas ME. Incidence, characteristics and outcomes of patients with severe CA-MRSA pneumonia. Eur Respir J. 2009 Jun 18. [Epub ahead of print].
  • Metaxas EI, Falagas ME. Update on the safety of linezolid. Expert Opin Drug Saf. 2009;8:485-91.
  • Vardakas KZ, Matthaiou DK, Falagas ME. Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta-analysis of randomized controlled trials. Eur J Neurol. 2009;16:662-73.
  • Falagas ME, Ierodiakonou V, Alexiou VG. Clinical practice of obtaining blood cultures from patients with a central venous catheter in place: an international survey. Clin Microbiol Infect. 2009 May 16. [Epub ahead of print].
  • Vouloumanou EK, Karageorgopoulos DE, Kazantzi MS, Kapaskelis AM, Falagas ME. Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2009 May 19. [Epub ahead of print].
  • Falagas ME, Rafailidis PI. Nephrotoxicity of Colistin: New Insight into an Old Antibiotic. Clin Infect Dis. 2009 May 13. [Epub ahead of print].
  • Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009 May 8. [Epub ahead of print].
  • Peppas G, Alexiou VG, Falagas ME. Mechanical Bowel Preparation for Elective Colorectal Surgery: Is It Enough? Reply. J Gastrointest Surg. 2009 May 9. [Epub ahead of print].
  • Pappas G, Athanasoulia AP, Matthaiou DK, Falagas ME. Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative? J Chemother. 2009;21:115-26.
  • Kopterides P, Falagas ME. Statins for sepsis: a critical and updated review. Clin Microbiol Infect. 2009;15:325-34.
  • Siempos II, Michalopoulos A, Falagas ME. Treatment of acute bacterial exacerbations of chronic bronchitis. Expert Opin Pharmacother. 2009;10:1173-82.
  • Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents. 2009 Apr 27. [Epub ahead of print].
  • Rafailidis PI, Kouranos VD, Christodoulou C, Falagas ME. Linezolid for patients with neutropenia: are bacteriostatic agents appropriate? Expert Rev Anti Infect Ther. 2009;7:415-22.
  • Grammatikos AP, Mantadakis E, Falagas ME. Meta-analyses on pediatric infections and vaccines. Infect Dis Clin North Am. 2009;23:431-57.
  • Matthaiou DK, Peppas G, Falagas ME. Meta-analysis on surgical infections. Infect Dis Clin North Am. 2009 ;23:405-30.
  • Siempos II, Dimopoulos G, Falagas ME. Meta-analyses on the prevention and treatment of respiratory tract infections. Infect Dis Clin North Am. 2009;23:331-53.
  • Vergidis PI, Falagas ME. Meta-analyses on behavioral interventions to reduce the risk of transmission of HIV. Infect Dis Clin North Am. 2009;23:309-14.
  • Vergidis PI, Falagas ME, Hamer DH. Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection. Infect Dis Clin North Am. 2009;23:295-308.
  • Rafailidis PI, Pitsounis AI, Falagas ME. Meta-analyses on the optimization of the duration of antimicrobial treatment for various infections. Infect Dis Clin North Am. 2009;23:269-76.
  • Leibovici L, Falagas ME. Systematic reviews and meta-analyses in infectious diseases: how are they done and what are their strengths and limitations? Infect Dis Clin North Am. 2009;23:181-94.
  • Falagas ME. The increasing body of research data in clinical medicine has led to the need for evidence synthesis studies. Preface. Infect Dis Clin North Am. 2009 Jun;23(2):xiii.
  • Agrafiotis M, Siempos II, Falagas ME. Agrafiotis M, Siempos II, Falagas ME. Respiration. 2009 Apr 10. [Epub ahead of print].
  • Vorgias G, Iavazzo C, Makarova E, Akrivos T, Falagas ME. Infections caused by Acinetobacter baumannii susceptible only to polymyxin in a gynecologic oncology unit. Int J Gynaecol Obstet. 2009 Mar 25. [Epub ahead of print].
  • Alexiou VG, Ierodiakonou V, Dimopoulos G, Falagas ME. Impact of patient position on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. J Crit Care. 2009 Feb 12. [Epub ahead of print].
  • Pitsouni E, Alexiou V, Saridakis V, Peppas G, Falagas ME. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2009 Mar 27. [Epub ahead of print].
  • Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE. Effect of body mass index on the outcome of infections: a systematic review. Obes Rev. 2009 Feb 19. [Epub ahead of print].
  • Falagas ME, Kastoris AC, Vouloumanou EK, Dimopoulos G. Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur J Clin Microbiol Infect Dis. 2009 Feb 18. [Epub ahead of print].
  • Christodoulou C, Pervena A, Klouvas G, Galani E, Falagas ME, Tsakalos G, Visvikis A, Nikolakopoulou A, Acholos V, Karapanagiotidis G, Batziou E, Skarlos DV. Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone. Oncology. 2009;76:209-211.
  • Falagas ME, Makris GC. Probiotic bacteria and biosurfactants for nosocomial infection control: a hypothesis. J Hosp Infect. 2009 Feb 5. [Epub ahead of print].
  • Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect. 2009;58:91-102.
  • Rosmarakis EE, Papageorgiou PG, Falagas ME. Open-access Web resources on cardiovascular infections and inflammations. Can J Cardiol. 2008;24:e11-5.
  • Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME. Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents. 2009 Jan 27. [Epub ahead of print].
  • Dandoulakis M, Roussos N, Karageorgopoulos DE, Yatromanolakis N, Falagas ME. Trends of tuberculin skin test positivity rate among schoolchildren in Attica, Greece. Scand J Infect Dis. 2009 Jan 23:1-6. [Epub ahead of print].
  • Falagas ME, Vouloumanou EK, Rafailidis PI. Systemic colistin use in children without cystic fibrosis: a systematic review of the literature. Int J Antimicrob Agents. 2009 Jan 23. [Epub ahead of print].
  • Korbila IP, Manta KG, Siempos II, Dimopoulos G, Falagas ME. Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: meta-analysis of randomized controlled trials. Can Fam Physician. 2009;55:60-7.
  • Vardakas KZ, Michalopoulos A, Kiriakidou KG, Siampli EP, Samonis G, Falagas ME. Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect. 2009 Jan 10. [Epub ahead of print].
  • Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol. 2008 Sep 19. [Epub ahead of print].
  • Falagas ME, Karageorgopoulos DE, Dimopoulos G. Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline. Curr Drug Metab. 2009;10:13-21.
  • Vardakas KZ, Kioumis I, Falagas ME. Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome. Curr Drug Metab. 2009;10:2-12.
  • Siempos II, Spanos A, Issaris EA, Rafailidis PI, Falagas ME. Non-physicians may reach correct diagnoses by using Google: a pilot study. Swiss Med Wkly. 2008;138:741-5.
  • Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol. 2008;101:570-9.
  • Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: A case series. Respir Med. 2008 Dec 30. [Epub ahead of print].
  • Falagas ME, Sideri G, Vouloumanou EK, Papadatos JH, Kafetzis DA. Intravenous Colistimethate (Colistin) Use in Critically Ill Children Without Cystic Fibrosis. Pediatr Infect Dis J. 2008 Dec 31. [Epub ahead of print].
  • Konstantinidou K, Mantadakis E, Falagas ME, Sardi T, Samonis G. Venetian rule and control of plague epidemics on the Ionian Islands during 17th and 18th centuries. Emerg Infect Dis. 2009;15:39-43.
  • Dimopoulos G, Velegraki A, Falagas ME. Ten year survey on antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrob Agents Chemother. 2008 Dec 29. [Epub ahead of print].
  • Falagas ME, Peppas G, Matthaiou DK, Karageorgopoulos DE, Karalis N, Theocharis G. Effect of meteorological variables on the incidence of lower urinary tract infections. Eur J Clin Microbiol Infect Dis. 2008 Dec 23. [Epub ahead of print].
  • Avgeri SG, Matthaiou DK, Dimopoulos G, Grammatikos AP, Falagas ME. Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents. 2008 Dec 17. [Epub ahead of print].
  • Grammatikos AP, Siempos II, Michalopoulos A, Falagas ME. Optimal duration of the antimicrobial treatment of ventilator-acquired pneumonia. Expert Rev Anti Infect Ther. 2008;6:861-6.
  • Vardakas KZ, Siempos II, Grammatikos A, Athanassa Z, Korbila IP, Falagas ME. Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ. 2008;179:1269-1277.
  • Kwa AL, Tam VH, Falagas ME. Polymyxins: a review of the current status including recent developments. Ann Acad Med Singapore. 2008;37:870-83.
  • Vouloumanou EK, Rafailidis PI, Kazantzi MS, Athanasiou S, Falagas ME. Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials. Curr Med Res Opin. 2008;24:3423-34.
  • Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008;8:751-62.
  • Athanassa Z, Makris G, Dimopoulos G, Falagas ME. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia : a meta-analysis. Drugs. 2008;68:2469-81.
  • Kyriakidou KG, Rafailidis P, Matthaiou DK, Athanasiou S, Falagas ME. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials. Clin Ther. 2008;30:1859-68.
  • Falagas ME, Grigori T, Ioannidou E. A systematic review of trends in the methodological quality of randomized controlled trials in various research fields. J Clin Epidemiol. 2008 Nov 13. [Epub ahead of print].
  • Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME. Do we still need the aminoglycosides? Int J Antimicrob Agents. 2008 Oct 29. [Epub ahead of print].
  • Falagas ME, Grammatikos AP, Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther. 2008;6:593-600.
  • Petrosillo N, Ioannidou E, Falagas ME. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect. 2008;14:816-27.
  • Christodoulou C, Murray S, Dahabreh J, Petraki K, Nikolakopoulou A, Mavri A, Skarlos D. Response of malignant thymoma to erlotinib. Ann Oncol. 2008;19:1361-2.
  • Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents. 2008 Sep 1. [Epub ahead of print].
  • Falagas ME, Matthaiou DK, Rafailidis PI, Panos G, Pappas G. Worldwide prevalence of head lice. Emerg Infect Dis. 2008;14:1493-4.
  • Falagas ME, Ierodiakonou V, Alexiou VG. At what age do biomedical scientists do their best work? FASEB J. 2008 Aug 27. [Epub ahead of print].
  • Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Grammatikos AP, Athanassa Z, Falagas ME. Abstract. Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia :A Meta-Analysis. Drugs 2008;68:1841-54.
  • German V, Sakagiannis G, Margaritis G, Falagas ME. Inka dinka don't. Herpes zoster. Am J Med. 2008 ;121:772-3.
  • Vergidis PI, Falagas ME. New antibiotic agents for bloodstream infections. Int J Antimicrob Agents. 2008 Aug 22. [Epub ahead of print].
  • Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2008;8:543-52.
  • Falagas ME, Vardakas KZ. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. Drug Saf. 2008;31:753-68.
  • Kapaskelis AM, Vouloumanou EK, Rafailidis PI, Hatzopoulou P, Nikita D, Falagas ME. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough. Respir Med. 2008 Aug 4. [Epub ahead of print].
  • Samonis G, Karageorgopoulos DE, Kofteridis DP, Matthaiou DK, Sidiropoulou V, Maraki S, Falagas ME. Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis. 2008 Aug 6. [Epub ahead of print].
  • Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother. 2008 Aug 1. [Epub ahead of print].
  • Falagas ME, Vouloumanou EK, Matthaiou DK, Kapaskelis AM, Karageorgopoulos DE. Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials. Mayo Clin Proc. 2008;83:880-9.
  • Korbila IP, Falagas ME. Investigational antimicrobial drugs for bloodstream infections. Curr Opin Investig Drugs. 2008;9:871-8.
  • Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother. 2008 Jul 28. [Epub ahead of print].
  • Falagas ME, Agrafiotis M, Athanassa Z, Siempos II. Administration of antibiotics via the respiratory tract as monotherapy for pneumonia. Expert Rev Anti Infect Ther. 2008;6:447-52.
  • Falagas ME, Alexiou VG. The top-ten in journal impact factor manipulation. Arch Immunol Ther Exp (Warsz). 2008 Jul 29. [Epub ahead of print].
  • Iavazzo C, Trompoukis C, Sardi T, Falagas ME. Conception, complicated pregnancy, and labour of gods and heroes in Greek mythology. Reprod Biomed Online. 2008;17 Suppl 1:11-4.
  • Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother. 2008 Jul 18 [Epub ahead of print].
  • Karamanis E, Peppas G, Alexiou VG, Falagas ME. World Wide Web resources on prevention and treatment of postoperative infections. Am J Surg. 2008;196:307-10.
  • Fragoulis KN, Michalopoulos A, Falagas ME. Open-access world wide web resources on sepsis. Clin Infect Dis. 2008;47:588.
  • Melakopoulos I, Karageorgopoulos DE, Christodoulou C, Skarlos DV, Falagas ME. Tooth and consequences. Am J Med. 2008;121:577-9.
  • Kondilis BK, Kiriaze IJ, Athanasoulia AP, Falagas ME. Mapping health literacy research in the European Union: a bibliometric analysis. PLoS ONE. 2008;3:e2519.
  • Mourtzoukou EG, Iavazzo C, Falagas ME. Resiniferatoxin in the treatment of interstitial cystitis: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jun 19. [Epub ahead of print].
  • Falagas ME, Rafailidis PI. Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs. 2008;17:973-81.
  • Rafailidis PI, Kapaskelis A, Falagas ME. Henoch-Schönlein purpura associated with Proteus mirabilis urinary tract infection. J Am Acad Dermatol. 2008;58:S98-9.
  • Pappas G, Fragoulis KN, Falagas ME. World Wide Web resources on zoonotic infections: a subjective overview. Trans R Soc Trop Med Hyg. 2008 May 29. [Epub ahead of print].
  • Falagas ME, Karageorgopoulos DE. Clinical Microbiology and Infectious Diseases (ECCMID) - 18th European Congress. Drug resistance among Gram-negative and Gram-positive bacteria. IDrugs. 2008;11:409-11.
  • Falagas ME, Mourtzoukou EG, Giannopoulou KP, Alexiou VG, Rafailidis PI. Matching criteria in case-control studies in the field of antimicrobial resistance. Microb Drug Resist. 2008;14:171-82.
  • Falagas ME, Zarkadoulia E. Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review. Curr Med Res Opin. 2008;24:1719-41.
  • Panos G, Samonis G, Alexiou VG, Kavarnou GA, Charatsis G, Falagas ME. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study. Curr HIV Res. 2008;6:257-60.
  • Rafailidis PI, Falagas ME. Discordance between data acquired by history and findings of physical examination: a phenomenal paradox. Eur J Intern Med. 2008;19:271-5.
  • Siempos II, Athanassa Z, Falagas. Frequency and predictors of ventilator –associated pneumonia recurrence: a meta-analysis. Shock. 2008 May 2. [Epub ahead of print].
  • Karamanis EM, Matthaiou DK, Moraitis LI, Falagas ME. Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine. 2008;33:E297-304.
  • Falagas ME, Tassios PT. Enhanced and earlier detection of bacteremia and fungemia by multiplex polymerase chain reaction: how much enhanced, how much earlier, and at what cost? Crit Care Med. 2008;36:1660-1.
  • Falagas ME, Siempos II. Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract. Eur Respir J. 2008;31:1138-9.
  • Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis. 2008;46:1121-2.
  • Falagas ME, Giannopoulou KP, Kokolakis GN, Rafailidis PI. Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis. 2008;46:1069-77.
  • Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother. 2008 Apr 24. [Epub ahead of print].
  • Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaioannou V, Ntani G, Samonis G, Falagas ME. Crit Care Med. 2008;36:807-11.
  • Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, Maraki S, Falagas ME. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: An analysis of microbiological data. Scand J Infect Dis. 2008;40:414-9.
  • Falagas ME, Kouranos VD, Arencibia-Jorge R, Karageorgopoulos DE. Comparison of SCImago journal rank indicator with journal impact factor. FASEB J. 2008 Apr 11. [Epub ahead of print].
  • Falagas ME, Athanasiou S, Iavazzo C, Tokas T, Antsaklis A. Urinary tract infections after pelvic floor gynecological surgery: prevalence and effect of antimicrobial prophylaxis. A systematic review. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Apr 10. [Epub ahead of print].
  • Iavazzo C, Vogiatzi C, Falagas ME. A retrospective analysis of isolates from patients with vaginitis in a private Greek obstetric/gynecological hospital (2003-2006). Med Sci Monit. 2008;14:CR228-231.
  • Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47.
  • Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, Dimopoulos G, Falagas ME. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ. 2008;178:845-54.
  • Michalopoulos A, Falagas ME. Colistin and polymyxin B in critical care. Crit Care Clin. 2008;24:377-91.
  • Falagas ME, Rafailidis PI, Makris GC. Bacterial interference for the prevention and treatment of infections. Int J Antimicrob Agents. 2008;31:518-22.
  • Falagas ME, Charitidou E, Alexiou VG. Article and journal impact factor in various scientific fields. Am J Med Sci. 2008;335:188-91.
  • Papassotiriou I, Alexiou VG, Tsironi M, Skenderi K, Spanos A, Falagas ME. Severe aseptic inflammation caused by long distance running (246 km) does not increase procalcitonin. Eur J Clin Invest. 2008;38:276-9.
  • Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus Praziquantel in the Treatment of Neurocysticercosis: A Meta-analysis of Comparative Trials. PLoS Negl Trop Dis. 2008;2:e194.
  • Falagas ME, Mourtzoukou EG, Ntziora F, Peppas G, Rafailidis PI. Matching criteria in case-control studies on postoperative infections. J Hosp Infect. 2008 Mar 6. [Epub ahead of print].
  • Rafailidis PI, Matthaiou DK, Varbobitis I, Falagas ME. Use of ACE inhibitors and risk of community-acquired pneumonia: a review. Eur J Clin Pharmacol. 2008 Mar 5. [Epub ahead of print].
  • Athanassa Z, Siempos II, Falagas ME. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J. 2008;31:625-32.
  • Rafailidis PI, Kapaskelis A, Christodoulou C, Galani E, Falagas ME. Concurrent M. tuberculosis, Klebsiella pneumoniae, and Candida albicans infection in liver metastasis of bowel carcinoma. Eur J Clin Microbiol Infect Dis. 2008 Feb 26. [Epub ahead of print].
  • Vardakas KZ, Horianopoulou M, Falagas ME. Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials. Diabetes Res Clin Pract. 2008;80:344-51.
  • Betsi GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008;9:93-103.
  • Falagas ME, Pitsouni EI, Bliziotis IA. Trends in the methodological quality of published randomized controlled trials on antibacterial agents. Br J Clin Pharmacol. 2008;65:942-54.
  • Mourtzoukou EG, Pappas G, Peppas G, Falagas ME. Vaccination of asplenic or hyposplenic adults. Br J Surg. 2008;95:273-80.
  • Panos G, Charatsis G, Paparizos V, Kazantzi M, Falagas ME. Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece. AIDS Res Hum Retroviruses. 2008;24:43-51.
  • Athanasiou S, Pitsouni E, Iavazzo C, Karamanis EM, Falagas ME. World wide web resources on obstetrical and gynecological infections. Infect Dis Obstet Gynecol. 2007;2007:29232.
  • Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol. 2008;12:5.
  • Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI. Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother. 2008 Feb 7; [Epub ahead of print].
  • Siempos II, Vardakas KZ, Falagas ME. Closed tracheal suction systems for prevention of ventilator-associated pneumonia. Br J Anaesth. 2008 Feb 4; [Epub ahead of print].
  • Peppas G, Alexiou VG, Falagas ME. Bowel Cleansing Before Bowel Surgery: Major Discordance Between Evidence and Practice. J Gastrointest Surg. 2008 Feb 5; [Epub ahead of print].
  • Vergidis PI, Falagas ME. Multidrug-resistant Gram-negative bacterial infections: The emerging threat and potential novel treatment options. Curr Opin Investig Drugs. 2008;9:176-83.
  • Falagas ME, Theocharis G, Spanos A, Vlara LA, Issaris EA, Panos G, Peppas G. Effect of meteorological variables on the incidence of respiratory tract infections. Effect of meteorological variables on the incidence of respiratory tract infections. Respir Med. 2008 Jan 30; [Epub ahead of print].
  • Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology. 2008 Feb 1;5(1):13 [Epub ahead of print].
  • Falagas ME, Polemis M, Alexiou VG, Marini-Mastrogiannaki A, Kremastinou J, Vatopoulos AC. Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece. Med Sci Monit. 2008;14:CR75-79.
  • Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg. 2008;106:523-9.
  • Falagas ME, Vardakas KZ, Mourtzoukou EG. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2008 Jan 25; [Epub ahead of print].
  • Iavazzo C, Pitsouni E, Athanasiou S, Falagas ME. Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia. Int J Gynaecol Obstet. 2008 Jan 25; [Epub ahead of print].
  • Alexiou VG, Falagas ME. e-meducation.org: an open access medical education web portal. BMC Med Educ. 2008 Jan 24;8(1):6 [Epub ahead of print].
  • Falagas ME, Kanellopoulou MD, Karageorgopoulos DE, Dimopoulos G, Rafailidis PI, Skarmoutsou ND, Papafrangas EA. Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin. Eur J Clin Microbiol Infect Dis. 2008 Jan 23; [Epub ahead of print].
  • Siempos II, Ioannidou E, Falagas ME. The difference between adequate and appropriate antimicrobial treatment. Clin Infect Dis. 2008 ;46:642-4.
  • Falagas ME. Reply to Kollef. Clin Infect Dis. 2008;46:480-481.
  • Pappas G, Kiriaze IJ, Falagas ME. Insights into infectious disease in the era of Hippocrates. Int J Infect Dis. 2008 Jan 4; [Epub ahead of print].
  • Falagas ME, Alexiou VG. An analysis of trends in globalisation of origin of research published in major general medical journals. Int J Clin Pract. 2008;62:71-5.
  • Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G; International Society of Chemotherapy; Institute of Continuing Medical Education of Ioannina. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007;4:e317.
  • Falagas ME, Siempos II, Vardakas KZ. Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Lancet Infect Dis. 2008;8:53-66.
  • Tsiodras S, Kelesidis T, Kelesidis I, Bauchinger U, Falagas ME. Human infections associated with wild birds. J Infect. 2007 Dec 21; [Epub ahead of print].
  • Falagas ME, Makris GC, Dimopoulos G, Matthaiou DK. Heteroresistance: a concern of increasing clinical significance? Clin Microbiol Infect. 2007 Dec 18; [Epub ahead of print].
  • Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Impact of passive humidification on clinical outcomes of mechanically ventilated patients: A meta-analysis of randomized controlled trials. Crit Care Med. 2007 Oct 16; [Epub ahead of print].
  • Laohaburanakit P, Dimopoulos G, Siempos II, Falagas ME, Irwin R. Antibiotic use in acute exacerbations of chronic bronchitis. Chest. 2007;132:2063-4.
  • Siempos II, Vardakas KZ, Kopterides P, Falagas ME. Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med. 2007;35:2843-51.
  • Pitsouni E, Iavazzo C, Falagas ME. Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: A metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2007 Dec 7; [Epub ahead of print].
  • Falagas ME, Kazantzi MS, Bliziotis IA. Comparison of utility of blood cultures from intravascular catheters and peripheral veins: a systematic review and decision analysis. J Med Microbiol. 2008;57:1-8.
  • Christodoulou C, Rizos M, Galani E, Rellos K, Skarlos DV, Michalopoulos A. Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU). Anticancer Res. 2007;27:2945-8.
  • Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study. Respir Med. 2007 Nov 28; [Epub ahead of print].
  • Vrachliotis TG, Falagas ME. Commentary: infections after endovascular coil embolization. J Endovasc Ther. 2007;14:805-6.
  • Falagas ME, Vardakas KZ, Samonis G. Decreasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials. Curr Med Res Opin. 2007 Nov 28; [Epub ahead of print].
  • Vardakas KZ, Falagas ME. Interpretation of the findings of a cohort study of bacteremic patients with community-acquired pneumonia. Chest. 2007;132:1715.
  • Rafailidis PI, Kapaskelis A, Falagas ME. Multifocal Pseudomonas aeruginosa myositis in an apparently healthy adult. Eur J Clin Microbiol Infect Dis. 2007 Nov 8; [Epub ahead of print].
  • Mastoraki E, Michalopoulos A, Kriaras I, Mouchtouri E, Falagas M, Karatza D, Geroulanos S. Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. J Infect. 2007 Nov 3; [Epub ahead of print].
  • Rosmarakis ES, Falagas ME. Thiazolidinedione therapy and restenosis after coronary stent implantation. Am Heart J. 2007;154(5):e43.
  • Fragoulis KN, Korbila IP, Dimopoulos G, Falagas ME. Open access World Wide Web resources on upper and lower respiratory tract infections. Int J Tuberc Lung Dis. 2007;11:1237-45.
  • Ioannidou E, Siempos II, Falagas ME. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother. 2007 Oct 19; [Epub ahead of print].
  • Vardakas KZ, Ntziora F, Falagas ME. Linezolid: effectiveness and safety for approved and off-label indications. Expert Opin Pharmacother. 2007;8:2381-400.
  • Trompoukis C, German V, Falagas ME. From the roots of parasitology: Hippocrates' first scientific observations in helminthology. J Parasitol. 2007;93:970-2.
  • Kwa A, Kasiakou SK, Tam VH, Falagas ME. Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther. 2007;5:811-21.
  • Falagas ME, Voidonikola PT, Angelousi AG. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Int J Antimicrob Agents. 2007 Oct 1; [Epub ahead of print]
  • Rosmarakis ES, Prapas SN, Rellos K, Michalopoulos A, Samonis G, Falagas ME. Nosocomial infections after off-pump coronary artery bypass surgery: frequency, characteristics, and risk factors. Interact Cardiovasc Thorac Surg. 2007 Sep 28; [Epub ahead of print].
  • Moutzouris DA, Manetas S, Mountantonakis SE, Falagas ME. Please treat me with metoclopramide. Emerg Med J. 2007;24:735-6.
  • Falagas ME, Karveli EA, Siempos II, Vardakas KZ. Acinetobacter infections: a growing threat for critically ill patients. Epidemiol Infect. 2007 Sep 25;:1-11 [Epub ahead of print].
  • Vardakas KZ, Siempos II, Falagas ME. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality. Diabet Med. 2007 Oct;24(10):1168-71.
  • Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 2007 Sep 20; [Epub ahead of print].
  • Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother. 2007 Sep 27; [Epub ahead of print].
  • Falagas ME, Bliziotis IA. Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials. Am J Med Sci. 2007;334:171-9.
  • Kopterides P, Mourtzoukou EG, Skopelitis H, Tsavaris N, Falagas ME. Aspects of the association between leishmaniasis and malignant disorders. Trans R Soc Trop Med Hyg. 2007 Sep 14; [Epub ahead of print].
  • Kopterides P, Koletsi PK, Michalopoulos A, Falagas ME. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates. Int J Antimicrob Agents. 2007 Sep 10; [Epub ahead of print].
  • Falagas ME, Alexiou VG. Editors may inappropriately influence authors' decisions regarding selection of references in scientific articles. Int J Impot Res. 2007;19:443-5.
  • Rafailidis PI, Kapaskelis A, Falagas ME. Cytomegalovirus meningitis in an immunocompetent patient. Med Sci Monit. 2007;13:CS107-109.
  • Falagas ME, Kopterides P. Old antibiotics for infections in critically ill patients. Curr Opin Crit Care. 2007 Oct;13:592-597.
  • Falagas ME, Rafailidis PI, Kapaskelis A, Peppas G. Pyomyositis associated with hematological malignancy: case report and review of the literature. Int J Infect Dis. 2007 Aug 25; [Epub ahead of print].
  • Rafailidis PI, Ioannidou EN, Falagas ME. Ampicillin/Sulbactam : current status in severe bacterial infections. Drugs. 2007;67:1829-49.
  • Falagas ME, Pappas VD, Michalopoulos A. Gangrenous, Hemorrhagic, Bullous Cellulitis Associated with Pseudomonas aeruginosa in a Patient with Waldenstrom's Macroglobulinemia. Infection. 2007 Aug 25; [Epub ahead of print].
  • Peppas G, Bliziotis IA, Oikonomaki D, Falagas ME. Abstract Outcomes after medical and surgical treatment of diverticulitis: A systematic review of the available evidence. J Gastroenterol Hepatol. 2007;22:1360-8.
  • Falagas ME, Karveli EA, Tritsaroli VI. The risk of using the Internet as reference resource: A comparative study. Int J Med Inform. 2007 Aug 20; [Epub ahead of print].
  • Athanasiou S, Anstaklis A, Betsi GI, Sotiropoulou M, Falagas ME. Clinical and urodynamic parameters associated with history of urinary tract infections in women. Acta Obstet Gynecol Scand. 2007;86:1130-5.
  • Bliziotis IA, Ntziora F, Lawrence KR, Falagas ME. Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials. Eur J Clin Microbiol Infect Dis. 2007 Aug 22; [Epub ahead of print].
  • Papadavid E, Stratigos AJ, Falagas ME. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer. Expert Opin Pharmacother. 2007;8:1743-55.
  • Mourtzoukou EG, Falagas ME. Exposure to cold and respiratory tract infections. Int J Tuberc Lung Dis. 2007;11:938-43.
  • Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007 Aug 16; [Epub ahead of print].
  • Korbila IP, Bliziotis IA, Lawrence KR, Falagas ME. Abstract Antibiotic-lock therapy for long-term catheter-related bacteremia: a review of the current evidence. Expert Rev Anti Infect Ther. 2007;5:639-52.
  • Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI. The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res. 2007 Jul 17;9(4):R44 [Epub ahead of print].
  • Falagas ME, Karveli EA, Panos G. Abstract Infectious disease cases for educational purposes: open-access resources on the Internet. Clin Infect Dis. 2007;45:495-500.
  • Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect. 2007;13:657-64.
  • Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol. 2007;178:880-5.
  • Falagas ME, Mourtzoukou EG, Polemis M, Vatopoulos AC; Greek System for Surveillance of Antimicrobial Resistance. Abstract Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications. Clin Microbiol Infect. 2007;13:816-9.
  • Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007;30:213-21.
  • Rosmarakis ES, Falagas ME. Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials. Am Heart J. 2007;154:144-50.
  • Christopoulos P, Falagas ME, Gourzis P, Trompoukis C. Aspects of informed consent in medical practice in the eastern mediterranean region during the 17th and 18th centuries. World J Surg. 2007;31:1587-91.
  • Fragoulis KN, Vardakas KZ, Falagas ME. Open access World Wide Web resources on urogenital infections. Nephrol Dial Transplant. 2007 Aug 3; [Epub ahead of print].
  • Rafailidis PI, Falagas ME. Fever and periorbital edema: a review. Surv Ophthalmol. 2007;52:422-33.
  • Dimopoulos G, Siempos II, Korbila IP, Manta KG, Falagas ME. Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials. Chest. 2007;132:447-55.
  • Falagas ME, Giannopoulou KP, Issaris EA, Spanos A. World databases of summaries of articles in the biomedical fields. Arch Intern Med. 2007;167:1204-6.
  • Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother. 2007;60:214-36.
  • Falagas ME, Giannopoulou KP, Ntziora F, Vardakas KZ. Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence. J Antimicrob Chemother. 2007;60:7-19.
  • Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101:1845-63.
  • Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care. 2007 May 31;11(3):134 [Epub ahead of print].
  • Falagas ME, Nikou SA, Siempos II. Infections related to coils used for embolization of arteries: review of the published evidence. J Vasc Interv Radiol. 2007;18:697-701.
  • Panos GZ, Xirouchakis E, Tzias V, Charatsis G, Bliziotis IA, Doulgeroglou V, Margetis N, Falagas ME. Helicobacter pylori infection in symptomatic HIV-seropositive and -seronegative patients: a case-control study. AIDS Res Hum Retroviruses. 2007;23:709-12.
  • Dimopoulos G, Karabinis A, Samonis G, Falagas ME. Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis. 2007;26:377-84.
  • Falagas ME, Bliziotis IA, Rafailidis PI. Do high doses of quinolones decrease the emergence of antibacterial resistance? A systematic review of data from comparative clinical trials. J Infect. 2007;55:97-105.
  • Ntziora F, Falagas ME. Linezolid for the treatment of patients with atypical mycobacterial infection: a systematic review. Int J Tuberc Lung Dis. 2007;11:606-11.
  • Rafailidis PI, Kapaskelis A, Falagas ME. Periorbital and facial swelling due to dermatomyositis. CMAJ. 2007;176:1580-1.
  • Falagas ME, Rafailidis PI. When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach. Shock. 2007;27:605-609.
  • Falagas ME, Pitsouni EI. Guidelines and consensus statements regarding the conduction and reporting of clinical research studies. Arch Intern Med. 2007;167:877.
  • Falagas ME, Giannopoulou KP, Ntziora F, Papagelopoulos PJ. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents. 2007 Apr 23; [Epub ahead of print].
  • Falagas ME, Velakoulis S, Iavazzo C, Athanasiou S. Mesh-related infections after pelvic organ prolapse repair surgery. Eur J Obstet Gynecol Reprod Biol. 2007 Apr 23; [Epub ahead of print].
  • Rafailidis PI, Kapaskelis A, Falagas ME. Knee septic arthritis due to Streptococcus pyogenes associated with acute thrombosis of the tibial and peroneal veins: case report and review of the literature. Scand J Infect Dis. 2007;39:368-70.
  • Siempos II, Falagas ME. Oral decontamination with chlorhexidine reduces the incidence of nosocomial pneumonia. Crit Care. 2007;11:402.
  • Falagas ME, Bliziotis IA, Michalopoulos A, Sermaides G, Papaioannou VE, Nikita D, Choulis N. Effect of a policy for restriction of selected classes of antibiotics on antimicrobial drug cost and resistance. J Chemother. 2007;19:178-84.
  • Rafailidis PI, Kakisi OK, Vardakas K, Falagas ME. Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials. Cancer. 2007 Apr 11; [Epub ahead of print].
  • Papadavid E, Falagas ME. World Wide Web resources of open access, educational dermatology clinical image quizzes and databases. J Am Acad Dermatol. 2007 Mar 15; [Epub ahead of print].
  • Falagas ME, Bliziotis IA, Rafailidis PI, Peppas G. Peripheral T-cell lymphoma masquerading as infectious cellulitis. Eur J Dermatol. 2007;17:166-167.
  • Falagas ME, Karydis I, Kostogiannou I. Percutaneous exposure incidents of the health care personnel in a newly founded tertiary hospital: a prospective study. PLoS ONE. 2007;2:e194.
  • Panos GZ, Karydis I, Velakoulis SE, Falagas ME. Multi-skeletal Pneumocystis jiroveci (carinii) in an HIV-seropositive patient. Int J STD AIDS. 2007;18:134-7.
  • Siempos II, Vardakas KZ, Manta KG, Falagas ME. Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia. Eur Respir J. 2007;29:548-60.
  • Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect. 2007;13:117-9.
  • Korres DS, Papagelopoulos PJ, Zahos KA, Kolia MD, Poulakou GG, Falagas ME. Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient. Transpl Infect Dis. 2007;9:62-5.
  • Falagas ME, Bliziotis IA, Fragoulis KN. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials. Am J Infect Control. 2007;35:106-14.
  • Falagas ME, Matthaiou DK, Karveli EA, Peppas G. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections. Aliment Pharmacol Ther. 2007;25:537-56.
  • Siempos II, Dimopoulos G, Korbila IP, Manta K, Falagas ME. Macrolides, quinolones, and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis. Eur Respir J. 2007 Feb 14; [Epub ahead of print].
  • Falagas ME, Kasiakou SK. Local Administration of Polymyxins into the Respiratory Tract for the Prevention and Treatment of Pulmonary Infections in Patients without Cystic Fibrosis. Infection. 2007;35:3-10.
  • Peppas G, Fragoulis KN, Falagas ME. Successful conservative management of large splenic infarct masquerading as infection. J Gastroenterol Hepatol. 2007;22:282-3.
  • Falagas ME, Bliziotis IA. Cost-effectiveness of different study designs: an overlooked parameter in clinical research. J Clin Epidemiol. 2007;60:215-6.
  • Pappas G, Falagas ME. Free internal medicine case-based education through the World Wide Web: how, where, and with what? Mayo Clin Proc. 2007;82:203-7.
  • Falagas ME, Rosmarakis ES, Prapas SN. Reply to the editor. J Thorac Cardiovasc Surg. 2007;133:591.
  • Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2007 Jan 25; [Epub ahead of print].
  • Siempos II, Fragoulis KN, Falagas ME. World wide web resources on control of nosocomial infections. Crit Care. 2007;11:101.
  • Panos GZ, Lampropoulos KM, Angelousi AG, Charatsis GG, Falagas ME. Lamivudine and Famciclovir Treatment in HIV Patients With Acute Hepatitis B Virus Infection and Hepatitis B Reactivation. J Clin Gastroenterol. 2007;41:222-223.
  • Falagas ME, Matthaiou DK, Bliziotis IA. Systematic review: fluoroquinolones for the treatment of intra-abdominal surgical infections. Aliment Pharmacol Ther. 2007;25:123-31.
  • Falagas ME, Vardakas KZ, Athanasiou S. Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: A systematic review. Eur J Pharmacol. 2006 Dec 12; [Epub ahead of print].
  • Kondilis B, Soteriades ES, Falagas ME. Readability levels of health pamphlets distributed during the Athens 2004 Olympic Games. Public Health. 2007 Jan 9; [Epub ahead of print] No abstract available.
  • Falagas ME, Bliziotis IA, Kondilis B, Soteriades ES. Eighteen Years of Research on AIDS: Contribution of and Collaborations between Different World Regions. AIDS Res Hum Retroviruses. 2006;22:1199-205.
  • Falagas ME, Ntziora F, Betsi GI, Samonis G. Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials. Int J Antimicrob Agents. 2007;29:136-43.
  • Falagas ME, Siempos II, Papagelopoulos PJ, Vardakas KZ. Linezolid for the treatment of adults with bone and joint infections. Int J Antimicrob Agents. 2007 Jan 2; [Epub ahead of print].
  • Falagas ME, Manta KG, Betsi GI, Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol. 2006 Dec 21; [Epub ahead of print].
  • Falagas ME, Fragoulis KN, Karydis I. A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories. PLoS ONE. 2006;1:e11.
  • Falagas ME, Kavvadia PK, Mantadakis E, Kofteridis DP, Bliziotis IA, Saloustros E, Maraki S, Samonis G. Morganella morganii Infections in a General Tertiary Hospital. Infection. 2006;34:315-21.
  • Siempos II, Falagas ME. Oral decontamination with chlorhexidine reduces the incidence of nosocomial pneumonia. Crit Care. 2006;10:R173.
  • Falagas ME, Siempos II, Bliziotis IA, Panos GZ. Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review. Mayo Clin Proc. 2006;81:1567-74.
  • Panos G, Kopterides P, Falagas ME. Hyperlactatemia due to nevirapine. Ann Intern Med. 2006;145:867-8.
  • Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents. 2006 Nov 23; [Epub ahead of print].
  • Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect. 2006;12:1227-30.
  • Falagas ME, Michalopoulos AS, Bliziotis IA, Soteriades ES. A bibliometric analysis by geographic area of published research in several biomedical fields, 1995-2003. CMAJ. 2006;175:1389-90.
  • Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006;55:1619-29.
  • German V, Giannakos G, Kopterides P, Liaskonis K, Falagas ME. Serologic indices of hepatitis B virus infection in military recruits in Greece (2004-2005). BMC Infect Dis. 2006;6:163.
  • Panos G, Karveli EA, Nikolatou O, Falagas ME. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol. 2006 Nov 8; [Epub ahead of print].
  • Falagas ME, Rosmarakis ES, Avramopoulos I, Vakalis N. Streptococcus agalactiae infections in non-pregnant adults: Single center experience of a growing clinical problem. Med Sci Monit. 2006;12:CR447-451.
  • Falagas ME, Zouglakis GM, Papastamataki PA. Trends in the impact factor of scientific journals. Mayo Clin Proc. 2006;81:1401-2.
  • Falagas ME, Karavasiou AI, Bliziotis IA. A bibliometric analysis of global trends of research productivity in tropical medicine. Acta Trop. 2006;99:155-9.
  • Falagas ME, Zarkadoulia EA, Bliziotis IA, Samonis G. Science in Greece: from the age of Hippocrates to the age of the genome. FASEB J. 2006;20:1946-50.
  • Horianopoulou M, Legakis NJ, Kanellopoulou M, Lambropoulos S, Tsakris A, Falagas ME. Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit. J Med Microbiol. 2006;55:1435-9.
  • Michalopoulos AS, Gregoriades K, Falagas ME. The effect of different arrangements of T-piece parts on oxygenation of patients with tracheostomy. Anesth Analg. 2006;103:1054-5.
  • Fragoulis KN, Christodoulou C, Falagas ME. Pain and a purple lesion. Am J Med. 2006;119:835-6.
  • Falagas ME. Abstract acceptance and blinded peer review. JAMA. 2006;296:1230.
  • Falagas ME, Kasiakou SK, Kofteridis DP, Roditakis G, Samonis G. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis. 2006;25:596-9.
  • Peppas G, Theocharis G, Karveli EA, Falagas ME. An analysis of patient house calls in the area of Attica, Greece. BMC Helth Serv Res. 2006;6:112.
  • Falagas ME, Kasiakou SK, Michalopoulos A. Polymyxins: a word of caution for prudent use of valuable "old antibiotics". Infect Control Hosp Epidemiol. 2006;27:995.
  • Falagas ME, Siempos II, Tsakoumis I. Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem. Scand J Infect Dis. 2006;38:807-10.
  • Falagas ME, Rosmarakis ES, Rellos K, Michalopoulos A, Samonis G, Prapas SN. Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2006;132:481-90.
  • Falagas ME, Siempos II, Bliziotis IA, Michalopoulos A. Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit Care. 2006;10:R123.
  • Panos GZ, Betsi GI, Falagas ME. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther. 2006;24:731-42.
  • Falagas ME, Angelousi AG, Peppas G. Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2006;55:537-8.
  • Matthaiou DK, Peppas G, Bliziotis IA, Falagas ME. Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials. Int J Antimicrob Agents. 2006;28:159-65.
  • Falagas ME, Karveli EA. World Wide Web resources on antimicrobial resistance. Clin Infect Dis. 200;43:630-3.
  • Falagas ME, Zarkadoulia EA, Samonis G. Arab science in the golden age (750-1258 C.E.) and today. FASEB J. 2006;20:1581-6.
  • Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for Prevention of Recurrent Urinary Tract Infections in Women : A Review of the Evidence from Microbiological and Clinical Studies. Drugs. 2006;66:1253-1261.
  • Kopterides P, Falagas ME. Potential consequences of the pneumococcal conjugate vaccine. N Engl J Med. 2006;355:95; author reply 95-6.
  • Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A. The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature. Clin Med Res. 2006;4:138-46.
  • Falagas ME, Kopterides P, Siempos II. Attributable Mortality of Acinetobacter baumannii Infection among Critically Ill Patients.Clin Infect Dis. 2006;43:389.
  • Falagas ME, Koletsi PK, Kopterides P, Michalopoulos A. Risk Factors for Isolation of Strains Susceptible Only to Polymyxin among Patients with Pseudomonas aeruginosa Bacteremia. Antimicrob Agents Chemother 2006;50:2541-3.
  • German V, Giannakos G, Kopterides P, Falagas ME. Prevalence and predictors of tuberculin skin positivity in Hellenic Army recruits. BMC Infect Dis 2006;6:102.
  • Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006;6:438-46.
  • Falagas ME, Kasiakou SK, Nikita D, Morfou P, Georgoulias G, Rafailidis PI. Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital. BMC Infect Dis 2006;6:99.
  • Falagas ME, Vardakas KZ. Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients. Clin Microbiol Infect 2006;12:603-5.
  • Falagas ME, Kavvadia P. "Eigenlob": self-citation in biomedical journals. FASEB J 2006;20:1039-42.
  • Falagas ME, Manta KG, Ntziora F, Vardakas KZ. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 2006 May 30; [Epub ahead of print]
  • Bliziotis IA, Kapaskelis AM, Kasiakou SK, Falagas ME. Limitations in the Management of Aortic Graft Infections. Ann Vasc Surg 2006 May 27; [Epub ahead of print]
  • Falagas ME, Kasiakou SK. Use of International Units When Dosing Colistin Will Help Decrease Confusion Related to Various Formulations of the Drug around the World. Antimicrob Agents Chemother 2006;50:2274-5
  • Falagas ME. Unique author identification number in scientific databases: a suggestion. PLoS Med 2006;3:249
  • Falagas ME, Bliziotis IA, Mavrogenis AF, Papagelopoulos PJ. Spondylodiscitis after facet joint steroid injection: a case report and review of the literature. Scand J Infect Dis 2006;38:295-9
  • Falagas ME, Zouglakis GM, Kavvadia PK. How masked is the "masked peer review" of abstracts submitted to international medical conferences? Mayo Clin Proc 2006;81:705
  • Falagas ME, Fragoulis KN, Bliziotis IA. Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2006 May 16; [Epub ahead of print]
  • Kanavaki S, Mantadakis E, Nikolaou S, Papavassiliou A, Karambela S, Anagnostou S, Falagas ME, Samonis G. Resistance of Mycobacterium tuberculosis isolates in different populations in Greece during 1993-2002. Int J Tuberc Lung Dis 2006;10:559-64
  • Samonis G, Maraki S, Leventakos K, Spanaki AM, Kateifidis A, Galanakis E, Tselentis Y, Falagas ME, Mantadakis E. Comparative effects of ertapenem, imipenem, and meropenem on the colonization of the gastrointestinal tract of mice by Candida albicans. Med Mycol 2006;44:233-5
  • Manetas S, Moutzouris DA, Falagas ME. Scalp necrosis: a rare complication of temporal arteritis. Clin Rheumatol 2006 May 6; [Epub ahead of print]
  • Falagas ME, Kiriaze IJ. Reaction to the threat of influenza pandemic: the mass media and the public. Crit Care 2006;10:408
  • Falagas ME, Bakossi A, Pappas VD, Holevas PV, Bouras A, Stamata E. Secular trends of blood isolates in patients from a rural area population hospitalized in a tertiary center in a small city in Greece. BMC Microbiol 2006;6:41
  • Michalopoulos A, Falagas ME. Multi-systemic methicillin resistant Staphylococcus aureus (MRSA) community-acquired infection. Med Sci Monit 2006;12:CS39-43
  • Falagas ME, Kasiakou SK. Continuous intravenous administration of antibiotics - Authors' reply. Lancet Infect Dis 2006 May;6:259-60
  • Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G, Morfou P. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 2006 Apr 20; [Epub ahead of print]
  • Falagas ME, Matthaiou DK, Bliziotis IA. Aminoglycosides in combination with a {beta}-lactam for the treatment of bacterial endocarditis: authors' response. J Antimicrob Chemother 2006 Apr 4; [Epub ahead of print]
  • Vassiloyanakopoulos A, Falagas ME, Allamani M, Michalopoulos A. Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user. J Med Microbiol 2006;55:635-8
  • Falagas ME, Bliziotis IA, Kapaskelis AM. Red streaks on the leg. Lymphangitis. Am Fam Physician 2006;73:1061-2
  • Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 2006;10:R48
  • Falagas ME, Vardakas KZ. Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients. Am J Hematol 2006;81:299-300
  • Falagas ME, Papastamataki PA, Bliziotis IA. A bibliometric analysis of research productivity in Parasitology by different world regions during a 9-year period (1995-2003). BMC Infect Dis 2006;6:56
  • Papagelopoulos PJ, Falagas ME. Editorial comment. Clin Orthop Relat Res 2006;444:2-3
  • Tsiodras S, Falagas ME. Clinical Assessment and Medical Treatment of Spine Infections. Clin Orthop Relat Res 2006;443:38-50
  • Falagas ME, Valotassiou VJ, Papadouli D, Papadopoulos A, Malamitsi J. 99mTechnetium-ciprofloxacin Scintigraphy for the Evaluation of Spinal Infections: A Preliminary Report. Clin Orthop Relat Res 2006;443:34-37
  • Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006;10:R27
  • Soteriades ES, Hadjichristodoulou C, Kremastinou J, Chelvatzoglou FC, Minogiannis PS, Falagas ME. Health promotion programs related to the Athens 2004 Olympic and Para Olympic games. BMC Public Health 2006;6:47
  • Falagas ME, Michalopoulos A. Polymyxins: old antibiotics are back. Lancet 2006;367:633-4.
  • Falagas ME, Matthaiou DK, Bliziotis IA. The role of aminoglycosides in combination with a {beta}-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 2006 Feb 24; [Epub ahead of print]
  • Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials. Crit Care Med. 2006 Apr 13; Publish Ahead of Print
  • Michalopoulos A, Geroulanos S, Rosmarakis ES, Falagas ME. Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg 2006 Feb 13; [Epub ahead of print]
  • Michalopoulus A, Falagas ME. The ingredients of a successful donation by brain death program in Greece. Am J Transplant 2006;6:642-3.
  • Falagas ME, Vardakas KZ, Michalopoulos A. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy - response to Prentice et al. Br J Haematol 2006;132:658-9.
  • Rellos K, Falagas ME, Vardakas KZ, Sermaides G, Michalopoulos A. Outcome of critically ill oldest-old patients (aged 90 and older) admitted to the intensive care unit. J Am Geriatr Soc 2006;54:110-4.
  • Fragoulis KN, Handrinou E, Papadopoulos V, Dardoufas K, Falagas ME. Delayed effusive pericarditis and recurrent pleural effusion after radiation treatment for Hodgkin's disease responsive to per os doxycycline. Eur J Haematol 2006;76:176-9.
  • Soteriades ES, Rosmarakis ES, Paraschakis K, Falagas ME. Research contribution of different world regions in the top 50 biomedical journals (1995-2002). FASEB J 2006;20:29-34.
  • Michalopoulos A, Prapas S, Falagas ME. The incidence of adult respiratory distress syndrome in patients undergoing off-pump coronary artery bypass grafting surgery. Eur J Anaesthesiol 2006;23:80.
  • Falagas ME, Fragoulis KN, Kopterides P. An analysis of the published Massachusetts General Hospital case records (1994-2004). Am J Med 2005;118:1452-3.
  • Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother 2006;50:22-33
  • Falagas ME, Fabritsi E, Chelvatzoglou FC, Rellos K. Penetration of the English language in science: the case of a German national interdisciplinary critical care conference. Crit Care 2005;9:655-6.
  • Michalopoulos A, Falagas ME. A bibliometric analysis of global research production in respiratory medicine. Chest 2005;128:3993-8.
  • Horianopoulou M, Lambropoulos S, Papafragas E, Falagas ME. Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis. J Chemother 2005;17:536-8.
  • Falagas ME, Vergidis PI. Urinary tract infections in patients with urinary diversion. Am J Kidney Dis 2005 Dec;46:1030-7.
  • Falagas ME, Kasiakou SK. Correct use of the term 'pan-drug-resistant' (PDR) Gram-negative bacteria. Clin Microbiol Infect 2005 Dec;11:1049-50.
  • Samonis G, Kofteridis DP, Maraki S, Alegakis D, Mantadakis E, Papadakis JA, Gikas AH, Falagas M. Levofloxacin and moxifloxacin increase human gut colonization by Candida species. Antimicrob Agents Chemother 2005 Dec;49:5189.
  • Falagas ME, Karageorgopoulos DE, Tansarli GS. Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis. PLoS One. 2013 Oct 21;8(10):e77075.
  • Falagas ME, Karageorgopoulos DE, Tansarli GS. Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis. PLoS One. 2013 Oct 21;8(10):e77075.
  • Pappas G, Ierodiakonou V, Falagas ME. Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe. Clin Ther. 2009;31:1595-603.
  • Michalopoulos A, Virtzili S, Rafailidis P, Chalevelakis G, Damala M, Falagas ME. Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clin Microbiol Infect. 2009 Aug 20. [Epub ahead of print].
  • Falagas ME, Alexiou VG, Peppas G, Makris GC. Do Changes in Antimicrobial Resistance Necessitate Reconsideration of Surgical Antimicrobial Prophylaxis Strategies? Surg Infect (Larchmt). 2009 Aug 18. [Epub ahead of print].
  • Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME. Antimicrobial susceptibility of urinary bacteria to fosfomycin. Antimicrob Agents Chemother. 2009 Aug 17. [Epub ahead of print].
  • Dimopoulos G, Falagas ME. Approach to the febrile patient in the ICU. Infect Dis Clin North Am. 2009;23:471-84.
  • Kouranos VD, Karageorgopoulos DE, Peppas G, Falagas ME. Comparison of adverse events between oral and intravenous formulations of antimicrobial agents: a systematic review of the evidence from randomized trials. Pharmacoepidemiol Drug Saf. 2009 Aug 3. [Epub ahead of print].
  • Falagas ME, Pappas VD, Michalopoulos A. Gangrenous, Hemorrhagic, Bullous Cellulitis Associated with Pseudomonas aeruginosa in a Patient with Waldenstrom's Macroglobulinemia. Infection. 2007 Aug 25; [Epub ahead of print].
  • Peppas G, Bliziotis IA, Oikonomaki D, Falagas ME. Abstract Outcomes after medical and surgical treatment of diverticulitis: A systematic review of the available evidence. J Gastroenterol Hepatol. 2007;22:1360-8.
  • Papadavid E, Stratigos AJ, Falagas ME. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer. Expert Opin Pharmacother. 2007;8:1743-55.
  • 3. Christou L, Pappas G, Falagas ME. Bacterial Infection-Related Morbidity and Mortality in Cirrhosis. Am J Gastroenterol. 2007;102:1510-7.
  • Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME. Hyaluronic Acid: An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis? Eur Urol. 2007;51:1534-41.
  • Korres DS, Papagelopoulos PJ, Zahos KA, Kolia MD, Poulakou GG, Falagas ME. Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient. Transpl Infect Dis. 2007;9:62-5.
  • Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents. 2007;29:630-6.
  • Ntziora F, Falagas ME. Linezolid for the Treatment of Patients with Central Nervous System Infection (February). Ann Pharmacother. 2007;41:296-308.
  • Falagas ME, Rafailidis PI, Rosmarakis ES. Arrhythmias associated with fluoroquinolone therapy. Int J Antimicrob Agents. 2007;29:374-9.
  • Moraitou E, Karydis I, Nikita D, Falagas ME. Case report: Parotid abscess due to Salmonella enterica serovar Enteritidis in an immunocompetent adult. Int J Med Microbiol. 2007;297:123-6.
  • Pappas G, Papadimitriou P. Falagas ME. World Wide Web. hepatitis B virus resources. J Clin Virol. 2007;38:161-4.
  • Soteriades ES, Falagas ME. A bibliometric analysis in the fields of preventive medicine, occupational and environmental medicine,epidemiology, and public health. BMC Public Health. 2006;6:301.
  • Falagas ME, Panos G. Implications of findings of bibliometric analyses in parasitology. Trends Parasitol. 2007;23:12-3.
  • Pappas G, Siozopoulou V, Akritidis N, Falagas ME. Doxycycline-rifampicin: Physicians' inferior choice in brucellosis or how convenience reigns over science. J Infect. 2007;54:459-62.
  • Falagas ME, Bliziotis IA, Soteriades ES.A prospective study of services utilization of a hospital-based employee health clinic. Med Sci Monit. 2006;12:CR341-344.
  • Falagas ME, Rosmarakis ES. Clinical decision-making based on findings presented in conference abstracts: is it safe for our patients? Eur Heart J. 2006;27:2038-9.
  • Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect. 2006;64:7-15.
  • Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 2006;66:1253-61.
  • Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 2006;25:419-25.
  • Kasiakou SK, Lawrence KR, Choulis N, Falagas ME. Continuous versus Intermittent Intravenous Administration of Antibacterials with Time-Dependent Action : A Systematic Review of Pharmacokinetic and Pharmacodynamic Parameters. Drugs 2005;65:2499-511.
  • Falagas ME, Fragoulis KN, Kasiakou SK, Sermaidis GJ, Michalopoulos A. Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents 2005 Nov 5; [Epub ahead of print]
  • Kondilis BK, Soteriades ES, Falagas ME. Health literacy research in Europe: a snapshot. Eur J Public Health 2005 Oct 17; [Epub ahead of print]
  • Falagas ME, Rosmarakis ES. Recurrent post-sternotomy mediastinitis. J Infect 2005 Oct 6; [Epub ahead of print]
  • Falagas ME, Vergidis PI. Irrigation with antibiotic-containing solutions for the prevention and treatment of infections. Clin Microbiol Infect 2005;11:862-7.
  • Kasiakou SK, Fragoulis K, Tzagarakis G, Mistidis P, Kapaskelis A, Falagas ME. Cure of Multidrug-Resistant Acinetobacter baumannii Fixation Device-Related Orthopedic Infections in Two Patients with Intravenous Colistin. Microb Drug Resist 2005;11:287-9.
  • Bliziotis IA, Michalopoulos A, Kasiakou SK, Samonis G, Christodoulou C, Chrysanthopoulou S, Falagas ME.Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clin Proc 2005;80:1146-56.
  • Falagas ME, Bliziotis IA. Reply to alfandari and boussekey. Clin Infect Dis 2005;41:1543-4.
  • Kasiakou SK, Peppas G, Kapaskelis AM, Falagas ME. Regression of skin lesions of Kyrle's disease with clindamycin: implications for an infectious component in the etiology of the disease. J Infect 2005;50:412-6.
  • Bliziotis I, Rafailidis P, Vergidis P, Falagas ME. Regression of subcorneal pustular dermatosis type of IgA pemphigus lesions with azithromycin. J Infect. 2005;51:E31-4.
  • Rafailidis PI, Prapas SN, Kasiakou SK, Costeas XF, Falagas ME. Effusive-constrictive calcific pericarditis associated with Streptococcus salivarius. Case report and review of the literature. Cardiol Rev 2005;13:113-7.
  • Rafailidis PI, Avramopoulos I, Sapkas G, Falagas ME. Multidrug-resistant tuberculous spondylodiscitis: need for aggressive management and drug susceptibility testing of Mycobacterium tuberculosis isolates. J Infect. 2005 Jul 1; [Epub ahead of print]
  • Rosmarakis ES, Kapaskelis AM, Kasiakou SK, Falagas ME. Case report: Wegener's granulomatosis presents as pulmonary infection. Am Fam Physician. 2005 Mar;71:1062, 1064.
  • Michalopoulos A, Kasiakou SK, Rosmarakis ES, Falagas ME. Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis 2005;37:142-5.
  • Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005;9:R53-9
  • Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005;11:115-21.
  • Falagas ME, Kasiakou SK. Mesh-related infections after hernia repair surgery. Clin Microbiol Infect 2005;11:3-8.
  • Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005;142:47-55.
  • Soteriades ES, Falagas ME. Comparison of amount of biomedical research originating from the European Union and the United States. BMJ 2005;331:192-4.
  • Fragoulis KN, Klouvas GD, Falagas ME. Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae. Am J Med 2005;118:925-7.
  • Kasiakou SK, Sermaides GJ, Michalopoulos A, Soteriades ES, Falagas ME. Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis 2005;5:581-9.
  • Michalopoulos A, Kasiakou SK, Falagas ME. The significance of different formulations of aerosolized colistin. Crit Care 2005;9:417-8.
  • Hadjichristodoulou C, Soteriades ES, Kolonia V, Falagas ME, Pantelopoulos E, Panagakos G, Mouchtouri V, Kremastinou J. Methodological aspects of a GIS-based environmental health inspection program used in the Athens 2004 Olympic and Para Olympic Games. BMC Public Health 2005;5:93.
  • Vardakas KZ, Soteriades ES, Chrysanthopoulou SA, Papagelopoulos PJ, Falagas ME. Perioperative anti-infective prophylaxis with teicoplanin compared to cephalosporins in orthopaedic and vascular surgery involving prosthetic material. Clin Microbiol Infect 2005;11:775-7.
  • Vardakas KZ, Michalopoulos A, Falagas ME. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol 2005;131:22-8.
  • Bliziotis IA, Samonis G, Vardakas KZ, Chrysanthopoulou S, Falagas ME. Effect of aminoglycoside/beta-lactam combination therapy versus beta lactam monotherapy on the emergence of antimicrobial resistance. Clin Infect Dis 2005;41:149-58
  • Soteriades ES, Falagas ME. Comparison of amount of biomedical research originating from European Union compared with the United States. Br Med J 2005;331:192-4
  • Vardakas KZ, Samonis G, Chrysanthopoulou SA, Bliziotis IA, Falagas ME. The role of glycopeptides as part of empirical treatment of febrile neutropenic patients: a meta-analysis of randomized controlled trials. Lancet Infect Dis 2005;5:431-9
  • Falagas ME, Kasiakou SK, Michalopoulos A. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia. J Cyst Fibros 2005;4:149-50
  • Falagas ME, Rizos M, Bliziotis IA, Rellos K, Kasiakou SK, Michalopoulos A. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 2005;5(1):1
  • Rafailidis PI, Prapas SN, Kasiakou SK, Costeas XF, Falagas ME. Effusive-constrictive calcific pericarditis associated with Streptococcus salivarious: case report and review of the literature. Cardiol Rev 2005;13:113-7
  • Vergidis PI, Karavasiou AI, Paraschakis K, Bliziotis I, Falagas ME. A bibliometric analysis of global trends of research productivity in Microbiology. Eur J Clin Microbiol Infect Dis 2005;24(5):342-6.
  • Rosmarakis ES, Vergidis PI, Soteriades ES, Paraschakis K, Papastamataki PA, Falagas ME. Estimates of global production in cardiovascular diseases research. Int J Cardiol 2005;100:443-9
  • Bliziotis I, Paraschakis K, Vergidis PI, Karavasiou AI, Falagas ME. Worldwide trends in quantity and quality of published articles in the field of infectious diseases. BMC Infect Dis 2005;5:16
  • Falagas ME, Karavasiou AI, Bliziotis I. Estimates of global research productivity in Virology (1995 – 2003). J Med Virol 2005;76:229-233
  • Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 2005;5:24
  • Rosmarakis ES, Vergidis PI, Soteriades ES, Kasiakou SK, Falagas ME. From conference abstract to full paper: differences between data presented in conferences and journals. FASEB J 2005;19:673-80
  • Bliziotis I, Kasiakou S, Baloyanni M, Falagas ME. A healthy woman with right upper quadrant discomfort on deep palpation. Am Fam Physician 2005;71:2353-5
  • Michalopoulos A, Bliziotis IA, Rizos M, Falagas ME. Worldwide research productivity in Critical Care Medicine. Crit Care 2005;9:R258-65
  • Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrobial Agents Chemother 2005;49:3136-3146
  • Rosmarakis ES, Kapaskelis AM, Rafailidis PI, Falagas ME. Association between Wegener's granulomatosis and increased antithyroid antibodies: report of two cases and review of the literature. Int J Clin Pract 2005;59:373-5.

επιστροφή στην κορυφή

Επικοινωνία

Άλφα Ινστιτούτο Βιοϊατρικών Επιστημών

Νεαπόλεως 9,
151 23 Μαρούσι,
Αθήνα, Ελλάδα
Τηλ.: 210-683-9600
E-mail: secreteriat@aibs.gr

Παθολόγος - Λοιμωξιολόγος - Ματθαίος Φαλάγγας, MD, MSc
Διευθυντής, Άλφα Ινστιτούτο Βιοϊατρικών Επιστημών (ΑΙΒΕ)

Εκπαιδευτικά Περιστατικά

Google Map

Ο χάρτης φορτώνεται από το Google Maps μόνο αν τον ζητήσετε.

Άνοιγμα στο Google Maps